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Abstract 
 
Biomarkers are particular physiological characteristics which may indicate the presence 
of a disease in the organism. The abnormal concentration of certain anions in specific 
locus in the organism could be related to some illnesses or undesirable physiological 
conditions and, consequently, would act as a biomarker for the diagnosis and/or 
monitoring of these diseases. Luminescent trivalent lanthanide complexes have been 
extensively used as optical probes for this kind of biomarkers due to their peculiar 
spectroscopic properties.  
 
In this work a library of lanthanide polyamino-polycarboxylate complexes with either 
pyridine or quinoline chromophore moieties with a 1,2-diaminocyclohexane backbone 
are studied. The formed complexes differ in charge, steric hindrance and lipophilicity, 
which strongly affect the stability and mobility/location of the complexes in the organism 
for the eventual performance of in vitro experiments in terms of cell viability and cell 
association.  
 
All the complexes have been found to be highly stable in water at physiological pH, with 
the luminescent species being the predominant ones in all cases. In addition, it has been 
proved that some of the complexes are promising luminescent sensors for the detection 
of lactate, bicarbonate and citrate, which are relevant biomarkers for the diagnosis of 
some diseases. Moreover, preliminary simulations have been performed on the speciation 
of the most promising complex ([Tb(bpcd)]+) in the presence of all the three anions at 
specific physiological concentrations. The complex appeared to have especial affinity for 
the citrate anion. All these results are of main importance in order to efficiently orientate 
forthcoming studies under more complex conditions (i.e. matrixes containing more 
potentially-interfering species) or on the use of these probes in in vitro experiments. 
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The demand for lanthanides has increased dramatically due to their unique properties, 
which are of great importance in many sectors (refer to Section 1.1.3.). The United States 
once was self-sufficient in lanthanides, but over the last 30 years they become import-
dependent, together with Europe.[4,5,14–16] Definitely, that turns the lanthanide issue into 
an important political and economic problem, as the most of the rare earth production is 
centred in China (Figure 1.3.b).[4,6,7] Therefore, the challenging recovery of lanthanides 
(and actinides) from end-of-life products (also called urban mining) and industrial waste 
streams has become an issue of concern to the scientific community, which has been 
increasing its efforts in this field during the last years.[2,6,11,17]  
Industrial waste streams may also be considered. They present less than a 1% rare-earth 
oxide concentration but, as the waste volumes are huge, the total amount of f-block metals 
in this sources is significant.[9] The recycling of lanthanides and actinides cannot replace 
the mining of rare earth ores, but it can complement it, which would help balance the 
oversupply of lanthanum and cerium from some minerals for the production of the 
valuable neodymium,[10] indispensable for the miniaturization of everyday life electronic 
devices, such as mobile phones or hard disks. 
 
 
1.1.3. Applications of lanthanides 
Due to their particular nuclear, metallurgical, chemical, catalytic, electrical, magnetic, 
and optical properties (mostly determined by their unique intra-4f transitions), lanthanides 
have widespread importance in many sectors and are critical to hundreds of applications 
(Table 1.3).[3–6,10,18] In addition, several lanthanide applications are highly specific and 
(for the moment) irreplaceable. For instance, europium is used in computer monitors and 
televisions as the red phosphor. Nevertheless, fibre-optic cables present long distance 
performance thanks to some erbium-doped fibre lengths, which act as LASER amplifiers. 
Even if both lanthanides are very expensive (250 – 1700 $/kg for Eu, ~700 $/kg for Er), 
they cannot be replaced by cheaper materials, as they alone present the required optical 
properties.[5] 
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Table 1.3.  Some applications of lanthanides.[5–7,10] 
Element Applications 
La Fuel catalyst, fuel cells and batteries, optical lenses, night vision 
instruments, carbon-arc lamps, cigarette lighters, optical fibres, X-ray 
films, LASERs… 
Ce Automobile and petroleum refining catalyst, metallurgical industry, glass 
polishing, carbon-arc lamps, self-cleaning ovens, cigarette lighters, 
military applications… 
Pr Aircraft engines, cigarette lighters, carbon-arc lamps, fibre optic, glass 
colouring… 
Nd Magnets (cell phones, computers, air bags, MRI…), colouring pigments, 
surgical LASERs, cigarette lighters… 
Pm Not naturally found on Earth. 
Sm Durable permanent magnets, thermos-resistant (aerospace and military 
applications), carbon-arc lamps, neutron absorber… 
Eu LASERs, TV and PC monitors… 
Gd Magneto-optic recording, MRI, radiation detector, temperature and 
oxidation-resistant alloys, TV phosphors… 
Tb Fuel cells, fluorescent lamps, magneto-optic recording… 
Dy Motors (Next-generation vehicle, energy-conserving home electronics, 
wind power generators…), miniaturization of electronics, LASER… 
Ho Scarce. No commercial uses yet (unusual magnetic properties). 
Er Fibre optic, medical LASERs, pink glass colorant, metallurgy, nuclear 
industry… 
Tm The rarest. Very expensive.  X-ray phosphors. 
Yb High electrical resistance under stress (stress monitoring). 
Lu Radioactive. Catalyst… 
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1.2. Properties of lanthanides 
1.2.1. Electronic configuration of lanthanides 
Lanthanides are characterized by filling the 4f orbitals gradually along the series. The first 
two lanthanides, lanthanum (La) and cerium (Ce), present an exception to the Aufbau 
principle, by filling the 5d orbital before the 4f (Table 1.4.). This happens since the 5d 
subshell presents lower energy than the 4f in the case of these two atoms. From 
praseodymium (Pr) to lutetium (Lu), orbitals are filled following the Aufbau principle, 
except in the case of the eighth lanthanide, gadolinium (Gd), whose energy necessary to 
add an electron to the 5d orbital is lower than the necessary to ‘break’ the stable half-
filling of the 4f orbital.[1] 
 
Mostly all trivalent lanthanide (Ln(III)) ions are paramagnetic, as they present unpaired 
4f electrons. La(III) and Lu(III) are exceptions, presenting 4f 0 and 4f 14 electronic 
configurations respectively (Table 1.4.). The seven unpaired electrons confer Gd(III)  
(4f 7) a high magnetic moment, which makes Gd(III) complexes very interesting for 
magnetism-related applications, such as MRI.[19] 
 
 
1.2.2. 4f shielding and lanthanide contraction 
The 4f electrons are more internal than the lower energy 5s and 5p ones. This results in 
the shielding of the 4f valence electrons from the ligands (they do not participate in bonds) 
and the marked independence of the spectroscopic and magnetic properties of lanthanides 
from the environment. Furthermore, the 4f orbital does not shield sufficiently the positive 
charges generated with increasing atomic number (z) along the lanthanide series. This 
generates a contraction of the outer orbitals (greater than expected) and the consequent 
more-than-expected decrease on the atomic and the Ln(III) ionic radii with increasing z 
(Table 1.5.). Some authors also attribute part of this so-called lanthanide contraction to 
relativistic effects (around 10% influence in the contraction).[1,20,21]  
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Table 1.4.  Ground state electronic configurations of the lanthanide (Ln) atoms and their most common 
ions shown in correct order of orbital filling.[22] 
Element Ln Ln3+ Ln4+ Ln2+ 
La [Xe] 5d 1 6s2 * [Xe]   
Ce [Xe] 4f 1 5d 1 6s2 * [Xe] 4f 1 [Xe]  
Pr [Xe] 4f 3 6s2 [Xe] 4f 2 [Xe] 4f 1  
Nd [Xe] 4f 4 6s2 [Xe] 4f 3 [Xe] 4f 2 [Xe] 4f 4 
Pm [Xe] 4f 5 6s2 [Xe] 4f 4   
Sm [Xe] 4f 6 6s2 [Xe] 4f 5  [Xe] 4f 6 
Eu [Xe] 4f 7 6s2 [Xe] 4f 6  [Xe] 4f 7 
Gd [Xe] 4f 7 5d 1 6s2 * [Xe] 4f 7   
Tb [Xe] 4f 9 6s2 [Xe] 4f 8 [Xe] 4f 7  
Dy [Xe] 4f 10 6s2 [Xe] 4f 9 [Xe] 4f 8 [Xe] 4f 10 
Ho [Xe] 4f 11 6s2 [Xe] 4f 10   
Er [Xe] 4f 12 6s2 [Xe] 4f 11   
Tm [Xe] 4f 13 6s2 [Xe] 4f 12  [Xe] 4f 13 
Yb [Xe] 4f 14 6s2 [Xe] 4f 13  [Xe] 4f 14 
Lu [Xe] 4f 14 5d 1 6s2 [Xe] 4f 14   
* Aufbau-anomalous electronic configurations 
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Table 1.5.  Atomic and ionic radii of lanthanides and Yttrium (Å) reported by Shannon (1976).[23] 
Also a new set of ionic radii in aqueous solution obtained from EXAFS experimental data is reported 
(values marked with *).[24] CN: coordination number 
Atom CN Ln Ln3+  Atom CN Ln Ln3+ 
La 8 
9 
10 
1.300 
1.356 
1.41 
1.160 
1.216 
1.27 
1.250* 
 Tb 8 
9 
1.134 
1.192 
0.994 
1.052 
1.090* 
Ce 8 
9 
10 
1.283 
1.336 
1.39 
1.143 
1.196 
1.25 
1.220* 
 Dy 8 
9 
1.167 
1.223 
 
1.027 
1.083 
1.075* 
Pr 8 
9 
1.266 
1.319 
1.126 
1.179 
1.200* 
 Ho 8 
9 
10 
1.155 
1.212 
1.26 
1.015 
1.072 
1.12 
1.055* 
Nd 8 
9 
10 
1.249 
1.303 
1.41 
1.109 
1.163 
1.27 
1.175* 
 Er 8 
9 
1.144 
1.202 
1.004 
1.062 
1.040* 
Pm 8 
9 
1.233 
1.284 
1.093 
1.144 
 Tm 8 
9 
1.134 
1.192 
0.994 
1.052 
1.025* 
Sm 8 
9 
1.219 
1.272 
1.079 
1.132 
1.140* 
 Yb 8 
9 
1.125 
1.182 
0.985 
1.042 
1.010* 
Eu 8 
9 
1.206 
1.260 
1.066 
1.120 
1.120* 
 Lu 8 
9 
1.117 
1.172 
0.977 
1.032 
0.995* 
Gd 8 
9 
1.193 
1.247 
1.053 
1.107 
1.105* 
 (Y) 8 
9 
1.159 
1.215 
1.019 
1.075 
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1.3. Coordination chemistry of Ln(III) in aqueous solution 
1.3.1. Coordination chemistry 
The most common oxidation state of lanthanides in aqueous solution is 3+. Lanthanide 
trivalent cations (Ln3+) are small and present high charge density (they are hard acids); 
the heavier they are, the greater is its charge density, which causes heavier Ln3+ to usually 
form complexes with higher stability than lighter ones.[1,25–28] As an example, we present 
the stability constants of some Ln3+ with the broadly used ligands ethylene-
diaminetetraacetic acid (EDTA) and diethylenetriaminepentaacetic acid (DTPA) (Figure 
1.4.) in Table 1.6., where we observe an increasing trend on the stability constants with 
increasing atomic number. 
 
 
 
 
H4 EDTA                                                                   H5 DTPA 
 
Figure 1.4. H4EDTA and H5DTPA. 
 
 
 
Table 1.6.  Stability constants (logβ) of some Ln3+ in aqueous solution (at T = 298.15 K and µ 
= 0.1 M NaCl) with EDTA4- and DTPA5-. Charges omitted for clarity. 
Ligand La Ce Pr Nd Sm Eu Gd Tb Dy Ho Er Tm Yb Lu 
EDTA 15.46 15.94 16.36 16.56 17.10 17.32 17.35 17.92 18.28 18.60 18.83 19.30 19.48 19.80 
DTPA 19.48 20.33 21.07 21.60 22.34 22.39 22.46 22.71 22.82 22.78 22.74 22.72 22.62 22.44 
µ: Ionic strength, properly defined in Chapter 3. 
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As hard acids, Ln3+ present a strong affinity towards hard bases like neutral (i.e. ethers)[29] 
or negatively-charged (i.e. carboxylates)[30] O-donors and N-donors[29,31].[32–34] Due to 
that, the most popular ligands for the formation of strong Ln(III) complexes are 
polyamino-polycarboxylates (PAPC), which present both, negatively-charged O- and 
neutral N-donor atoms.[25,31,32,34–42]   (Figures 1.5. and 1.6.) Thus, PAPC are broadly used 
in applications where higly stable Ln(III) complexes are needed, such as biomedical 
applications,[37,43–45] where ligands have to overcome the high stability of Ln(III) hydrates 
(Section 1.3.3.) and the presence of toxic free Ln3+ in the body has to be avoided[34,46].  
 
The stability of a complex is quantitatively related to its formation constant (logβ, 
properly defined in Section 3.2.1.2.), which is at the same time related to its free energy 
of formation (ΔG0, properly defined in Section 3.2.5.). ΔG0 depends on the formation 
enthalpy (ΔH0) and entropy (ΔS0) of the complex (Equation 3.13.). As hard acids, Ln3+ 
ions usually present low enthalpies (either positive or negative) and high entropy 
values.[1,47] In other words, the formation of Ln(III) complexes is entropically driven. 
Thus, given the formation of a Ln(III) complex in water, represented in Equation 1.1., it 
is not difficult to deduce that a multidentate ligand (L, N=1, where N is associated to the 
number of ligand molecules, free or not) would displace more water molecules from the 
first coordination sphere than a monodentate one (N>1), which would cause at the same 
time the rising of n (associated to the number of ‘free’ water molecules) and, 
consequently, there would be a greater increment in entropy.[1,30,48] The low enthalpy 
values can be explained by the high stability of the Ln(III) hydrate complexes (Section 
1.3.3.), which is similar to that of the Ln(III) complex.[30] Moreover, the formed complex 
presents a lower overall charge density, which reduces the additional ordination of the 
solvent in the second coordination sphere. 
 
 [𝐿𝑛(𝐻2𝑂)𝑥](𝑎𝑞)3+ + 𝑁𝐿(𝑎𝑞)𝑦− ⇌ [𝐿𝑛(𝐿)𝑁(𝐻2𝑂)𝑥−𝑛](𝑎𝑞)(3−𝑦) + 𝑛𝐻2𝑂(𝑙)           Equation 1.1. 
 
 
Actually, it is well known that polydentate ligands present higher stability than an 
equivalent amount of monodentate ligands presenting the same number and type of donor 
atoms.[49–51]  
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Thus, the high thermodinamical stability of Ln(III) complexes with PAPC is also 
enhanced due to the multidentate nature of these ligands, which acts also as a chelating 
agent: polydentate ligands coordinate to the metal occupying at least two positions in the 
first coordination sphere, giving rise to cyclic structures which confer additional stability 
to the complex. The complexes presenting these cyclic structures are called chelated 
complexes, and the ligand that chelates the metal is called chelating agent.[30,47] 
 
1.3.2. Coordination numbers, bonding and geometry 
Lanthanide coordination numbers (CN) are diverse and may be rather large, presenting 
values usually from 6 to 12, but also lower values (2-3)[1] are known.[1,21,52–54] CN also 
depends on the Ln3+ radius and strongly on the ligand. In other words, CNs depend mainly 
on steric factors rather than crystal field effects, principally due to the shielding of the 4f 
valence electrons, which lightly contribute in the formation of the bonds.[46,54] Therefore, 
lanthanide complexes have a strong ionic character and, consequently, their bonds are 
rather labile and largely electrostatic.[32,46]  
 
Thus, the prediction of the geometry and the speciation of lanthanide complexes is not 
trivial; there are not strong directional forces that dictate unambiguous coordination 
geometries and some factors, such as steric effects, and electrostatic attraction/repulsion, 
may become of main importance.[1,46,52,55] For instance, regarding electrostatic effects, for 
small ligands (namely water, hydroxide or halides) the CN depends on the amount of 
ligands fitting around the metal without repulsing each other (first-order effects). On the 
other hand, and regarding steric effects, large ligands difficult large CNs due to their 
bulky surroundings (second-order effects).[1,45]  
 
1.3.3. Ln3+ in water 
When the number of donor atoms of the complexing ligand is low, the complex may 
complete its coordination sphere with solvent molecules (e.g. water). Ln3+ ions easily 
form hydrated complexes, as they present very high hydration free energies (table 1.7.).[1]  
 
In former studies, the CN of lanthanides with water in aqueous solution was thought to 
be 9 for the early lanthanides (La-Sm) and 8 for the later ones (Dy-Lu), with intermediate 
lanthanides (Eu, Gd and Tb) showing either of both or mixtures in equilibrium (the so-
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called gadolinium break).[1,23] But recent studies[24] affirm that n = 9 for all [Ln(H2O)n]3+ 
in aqueous solution, except for Ln = Lu (n = 8). 
 
Table 1.7.  Hydration free energies (-ΔG0hyd (kJ/mol))[38]  of Ln3+ ions.  
 La Ce Pr Nd Sm Eu Gd Tb Dy Ho Er Tm Yb Lu 
-ΔGhyd 
kJmol 
3300 3359 3392 3419 3490 3522 3539 3561 3600 3612 3632 3673 3702 3718 
 
 
 
1.4. Luminescence of trivalent lanthanide complexes 
1.4.1. Luminescence 
Due to the Laporte-forbidden f-f transitions, lanthanides present particularly small 
absorption coefficients.[59] Thus, a photosensitation of the lanthanide luminescence is 
needed. To do so, an adequate ligand has to be chosen, presenting an organic antenna 
chromophore near the lanthanide cation capable to absorb the exciting light and 
efficiently transfer the energy to the metal centre. This process is called the antenna effect, 
and it is fundamental in the design of bright luminescent lanthanide complexes.[1,55,57,60]  
 
In order to quantify the photosensitizing efficiency of the ligand, the term quantum yield 
(Φ) is used. The total quantum yield (Φtot) is the product of i) the intersystem crossing 
(ΦISC), ii) the energy transfer (ΦET) and iii) the lanthanide luminescence (ΦLn) (Equation 
1.2.).[46]  
 
Φtot = ΦISC· ΦET· ΦLn                                                                 (Equation 1.2.) 
 
 
The generally accepted photosensitation mechanism in lanthanide complexes is shown, 
in a simplified way, in Figure 1.7., where the Φ components are represented in their 
corresponding steps. It is important that the lower triplet state of the antenna presents 
higher energy (Δ𝐸 ≥ 1850 cm-1) than the highest luminescent state of the lanthanide 
cation, in order to avoid back energy transfer to the antenna’s triplet state. But, at the 
same time, the gap has to be as low as possible in order to assure the highest Φ.[61] 
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Figure 1.7. Energy conversion process (antenna effect) in luminescent lanthanide complexes. 
 
High Φtot values are also related to a large energy gap between the highest ground state 
level and the lowest excited energy level (radiative energy level) of the lanthanide ion. 
As it can be seen in the adapted Dieke’s diagram in Figure 1.8. (modified from 
literature)[62], the lanthanide ions presenting the largest gaps are Eu(III), Gd(III) and 
Tb(III). Consequently, they present the strongest luminescence among the lanthanides 
and their luminescent complexes are less affected by the quenching effect caused by the 
O-H vibrations of water molecules.[63] This is of main importance when working in 
bioapplications such as the sensing of biomarkers, as they have to show good performance 
in aqueous solution. Among those three Ln(III), Eu(III) and Tb(III) are the most used for 
luminescent applications, as Gd(III) emits into the UV region (310nm), which incites 
undesired background fluorescence from biological matrices and hinders its use in 
bioapplications. On the other hand, Eu(III) and Tb(III) emit into the visible  
spectra.[46,55,57,63] 
 
Absorption and luminescence spectra are unusually sharp for lanthanide complexes due 
to the formally forbidden nature of the f-f electronic transitions, and they remain mostly 
unaffected by the environment (Figure 1.9.).[46,55,64,65] Ln(III) also exhibit long 
luminescence lifetimes (10-6 →10-3 s, organic dyes usually present 10-9 s lifetimes). This 
fact is especially interesting for its use in bioapplications, as the undesired short-lived 
background luminescence from the biological matrix may be avoided by using time-
delayed spectroscopic techniques (Figure 1.10.).[46,60,63,64]  
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Figure 1.10. Graphic explanation of the time-delayed (or time-gated) measures, redrawn[64].  
 
 
1.4.2. Luminescent sensing of biomarkers 
Biomarkers are defined as ‘a characteristic that is objectively measured and evaluated as 
an indicator of normal biologic processes, pathogenic processes, or pharmacologic 
responses to a therapeutic intervention’. One of these ‘characteristics’ may be the 
concentration of certain molecules in the organism which, in abnormal concentrations, 
may indicate the presence of a disease. Thus, they are very useful for the screening, early 
diagnosis and monitoring of many illnesses.[66]  
 
Luminescent trivalent lanthanide complexes have been extensively used as probes for 
biomarkers due to their exceptional optical properties which have been already discussed. 
For instance, the determination of pH in cells and tissues is of main importance in 
analytical, biomedical and diagnostic studies, as it is a crucial feature for many 
physiological activities. In luminescent Ln(III) complexes, protonation or deprotonation 
of the antenna moieties can lead to perceptible changes in the energy absorption and/or 
transfer to the metal, which generates a noticeable change on the emission intensity 
(Figure 1.11.). Most pH luminescent sensors are developed regarding that pH 
dependence,[60,67,68] and many recent examples of pH sensors and pH-regulated Ln(III) 
complexes for imaging applications can be found in literature [69–72].  
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Chapter 2 
Aim of this thesis  
 
 
2.1. Aim 
Trivalent lanthanide (Ln(III)) complexes present unique f→f transition properties. They 
can be used in complex biological matrices due to their long emission lifetimes, which 
permit the isolation of their emission from the undesired background fluorescence.[1] 
 
Moreover, Eu(III) and mainly Tb(III) present low sensitivity to quenching caused by non-
radiative absorbing species such as water, which makes them suitable for applications in 
aqueous media. Furthermore, the intensity of the luminescent response of these 
complexes is usually related to the concentration of target analyte,[2–7] and can be 
incremented by using ligands which promote the antenna effect.[2,3,8,9]  
 
In view of all those particular proprieties, it is not surprising that Ln(III) complexes have 
been broadly studied for their use in several biomedical fields, such as medical 
diagnostics and luminescent sensing. Some of them, based on luminescent Eu(III) and 
Tb(III) complexes, have been successfully commercialized for the detection of relevant 
clinical biomarkers in biomedical diagnostics and imaging.[1]  
 
The study of the stability, speciation and structure of these luminescent Ln(III) complexes 
in water is of main importance as: 
 
■ It is necessary to assure the stability of the proposed complexes in water, 
especially around pH 7.4, as probes have to be physiologically compatible. 
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■ We have to guarantee that the luminescent Ln(III) complex is the predominant 
species in solution at pH 7.4 in order to assure that mostly all the luminescent 
response is due to that species. 
■ The structure of the Ln(III) complexes should present water molecules directly 
coordinated to the metal centre to permit the entrance of the anionic 
biomarkers into the inner coordination sphere by replacing the water 
molecules. This is of main importance, as it is actually how our biomarkers 
will be sensed, as already described in section 1.4.2.. 
 
In this work, a thoughtful library of Eu(III) and Tb(III) complexes has been studied 
potentiometrically, spectrophotometrically, calorimetrically and computationally in order 
to state their stability in water, their structure and their speciation at physiological pH. 
Furthermore, their viability as luminescent probes for the chosen anionic biomarkers has 
been studied by assessing their affinity for the target anions via calorimetric, luminescent 
and computational techniques, and their capacity for the actual sensing of these 
biomarkers by luminescent techniques.  
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Chapter 3 
Instrumentation and techniques  
 
 
3.1. Stock solutions and standardisation 
3.1.1. Solvent 
All the stock solutions were prepared with distilled water further purified with a Milli-Q 
system (>18 MΩ cm, ELGA Purelab Option-Q). Water was boiled before use in order to 
remove the solved atmospheric CO2, which would act as a protolytic impurity (Equation 
3.1.a and b).[1–4] 
 
CO2(aq) + H2O(l) ⇌ H2CO3(aq)                                       Equation 3.1.a 
NaOH(aq) + H2CO3(aq) ⇌ NaHCO3(aq) + H2O(l)             Equation 3.1.b 
 
 
3.1.2. Stock solutions 
Fresh HCl and NaOH 0.1M stock solutions where prepared regularly with high purity 
commercial products. HCl was standardized by volumetric titration with the primary 
standard disodium tetraborate in the presence of methyl red indicator. NaOH was 
standardized with the freshly standardized HCl stock and phenolphthalein.  
 
Eu(III) and Tb(III) stock solutions were prepared by dissolving their chloride hexahydrate 
salts. The lanthanide content in the stock solutions was determined by EDTA titration, 
using xylenol orange as indicator in a pH 5.5 acetic acid / acetate buffer.  
 
The stock solution of L-lactate was prepared by diluting its sodium salt. 
 
 
Chapter 3  
 
28 
 
3.2. Determination of equilibrium constants 
3.2.1. Principles and definitions 
3.2.1.1. Activity and concentration 
Given a generic species S, its activity and concentration can be related by using Equation 
3.2., where As is the activity of S, [S] is its concentration and γs the activity coefficient of 
S, which is constant when the ionic strength (µ) and temperature (T) of the system are 
kept constant.[1,5] 
 
As  =  γs ·  [S]                                             Equation 3.2. 
 
 
During the performance of our experiments, T (298.15 K) and µ (0.1 M) are kept constant 
in order to deal with concentrations instead of activities. Thus, when we use some relevant 
concepts and equations, such as pH (Equation 3.3.a) and Nernst equation (Equation 3.4.a), 
we will take concentrations in consideration instead of activities. Therefore, instead of 
Equation 3.3.a we will use Equation 3.3.b (from now on, p[H] will be simply written as 
pH), and instead of Equation 3.4.a we will use Equation 3.4.b, where E is the observed 
emf, E0 is the standard emf for the redox couple 𝑆𝑧+/𝑆(𝑧−𝑛)+, n is the number of electrons 
involved in the reduction of S, R is the gas constant and F is the Faraday constant. E0’ is 
a modified standard emf (Equation 3.4.c), and it will be written as E0 from now on. 
 
 𝑝𝐻 =  −𝑙𝑜𝑔 𝑎𝐻+                                    Equation 3.3.a 𝑝[𝐻] =  −𝑙𝑜𝑔[𝐻+]                                    Equation 3.3.b 
 
 𝐸 = 𝐸0 + 𝑅𝑇𝑛𝐹 𝑙𝑛 𝑎𝑆𝑧+𝑎𝑆(𝑧−𝑛)+                              Equation 3.4.a 
 𝐸 = 𝐸0′ + 𝑅𝑇𝑛𝐹 𝑙𝑛 [𝑆𝑧+][𝑆(𝑧−𝑛)+]                              Equation 3.4.b 
 𝐸0′ = 𝐸0 + 𝑅𝑇𝑛𝐹 𝑙𝑛 𝛾𝑆𝑧+𝛾𝑆(𝑧−𝑛)+                             Equation 3.4.c 
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3.2.1.2. Equilibrium constants 
The equilibrium constant 𝐾 of a generic reaction (Equation 3.5.a) can be defined as the 
quotient between the activities of products and reactants (Equation 3.5.b) at equilibrium.  
But, as we have already discussed, as we are working at constant temperature and ionic 
strength, activities might be substituted by concentrations to give a modified 𝐾′ (Equation 
3.5.c) which, from now on, will be simply called K.[1] 
 
 𝑏𝐵 + 𝑐𝐶 ⇌ 𝑑𝐷 + 𝑒𝐸                                Equation 3.5.a 𝐾 = 𝑎𝐷𝑑 ·𝑎𝐸𝑒𝑎𝐵𝑏 ·𝑎𝐶𝑐                                               Equation 3.5.b 𝐾′ = [𝐷𝑑]·[𝐸𝑒][𝐵𝑏]·[𝐶𝑐] =  K                                     Equation 3.5.c 
 
Throughout this work, two different definitions of equilibrium constant will be used K 
(the already-defined stepwise equilibrium constant) and β (the overall equilibrium 
constant or formation constant). The former one is more intuitive and popular, and will 
be sometimes used for the comparison of the obtained results with bibliography. The latter 
one was used for computational purposes (definition required by the software used for 
the fitting of the constants) and will be defined hereafter.  
 
Given a generic successive stepwise protonation, K 1, K 2 and K 3 can be defined 
(Equations 3.6.a-c).[1] 
 
 𝐿3− + 𝐻+ ⇌ 𝐿𝐻2− ;      𝐾1 = [𝐿𝐻2−][𝐿3−]·[𝐻+]                       Equation 3.6.a 
 𝐿𝐻2− + 𝐻+ ⇌ 𝐿𝐻2− ;      𝐾2 = [𝐿𝐻2−][𝐿𝐻2−]·[𝐻+]                       Equation 3.6.b 
 𝐿𝐻2− + 𝐻+ ⇌ 𝐿𝐻3 ;      𝐾3 = [𝐿𝐻3][𝐿𝐻2−]·[𝐻+]                       Equation 3.6.c 
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Given three overall protonation reactions for the same molecule, β1, β2 and β 3 can be 
defined (Equations 3.7.a-c). The mathematical relation between K and β values are also 
shown in Equations 3.7.a-c. For simplicity, usually the logarithm of these constants is 
reported. The mathematical relation between log K and log β values are easily deduced 
from Equations 3.7.a-c, and shown in Equations 3.8.a-c.[1] 
 
 𝐿3− + 𝐻+ ⇌ 𝐿𝐻2− ;      𝛽1 = [𝐿𝐻2−][𝐿3−]·[𝐻+] = 𝐾                               Equation 3.7.a 
 𝐿3− + 2𝐻+ ⇌ 𝐿𝐻2− ;      𝛽2 = [𝐿𝐻2−][𝐿3−]·[𝐻+]2 = 𝐾1 · 𝐾2                        Equation 3.7.b 
 𝐿3− + 3𝐻+ ⇌ 𝐿𝐻3 ;      𝛽3 = [𝐿𝐻3][𝐿3−]·[𝐻+]3 =  𝐾1 · 𝐾2 · 𝐾3              Equation 3.7.c 
 
 𝑙𝑜𝑔𝛽1 =  𝑙𝑜𝑔𝐾1                                                       Equation 3.8.a 𝑙𝑜𝑔𝛽2 =  𝑙𝑜𝑔𝐾1 + 𝑙𝑜𝑔𝐾2                                        Equation 3.8.b 𝑙𝑜𝑔𝛽3 =  𝑙𝑜𝑔𝐾1 + 𝑙𝑜𝑔𝐾2 + 𝑙𝑜𝑔𝐾3                          Equation 3.8.c 
 
 
3.2.2. Acid-base titrations 
3.2.2.1. Overview 
Potentiometric and spectrophotometric acid-base titrations have been performed in order 
to obtain mostly all the equilibrium constants found during this work. When possible, 
potentiometry was used, as it is one of the most accurate and precise techniques for the 
determination of equilibrium constants, and one of the most used for this scope.[6] The 
recommended concentration of ligand to perform this technique with good results is 
around 1 mM.[1] Thus, when reaching the required concentration was not possible due to 
solubility problems or lack of the necessary amounts of ligand, spectrophotometric acid-
base titrations where performed. The latter technique can also offer additional information 
about the protonation and complexation sites when the chromophore moieties of the 
molecule are involved (further explanation and examples in the forthcoming chapters). 
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3.2.2.2. Experimental 
In order to keep ionic strength constant, all acid-base titrations were performed in 0.1 M 
NaCl. The titration cell was maintained at constant temperature (298.2 K ± 0.1 K) using 
a circulatory bath. The emf was collected by means of a combined glass electrode 
(Metrohm Unitrode 6.0259.100) connected to a computer-controlled potentiometer 
(Amel Instruments, 338 pH Meter). The initial solution was intensely bubbled with N2 
while the system was reaching thermal equilibrium. During experiments, a low N2 flux 
was maintained over the closed system in order to avoid CO2 from reaching the solution. 
The N2 flux was previously passed through a NaOH trap in order to capture the eventual 
CO2 present in the N2. In the case of spectrophotometric titrations, also a fibre-optic 
probe, with a 10 mm path length, connected to a computer-controlled Varian Cary 50 
instrument, was immersed into the solution in order to record absorbance data. NaOH 
was added by means of an automatic burette (Metrohm Dosimat 665) manually 
(spectrophotometry) or automatically (potentiometry). The solution was continuously 
gently stirred by means of a magnetic stirrer. The systems described have been 
schematized in Figure 3.1.. 
 
 
 
 
 
Figure 3.1. Schemes of the system for the performance of the a) potentiometric  
and b) spectrophotometric acid-base titrations. 
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The electrode was calibrated potentiometrically (modified Nernst equation, Equation 
3.4.b) before each titration by an acid-base titration with standard HCl and NaOH 0.1 M 
stock solutions and the carbon dioxide present in solution was checked by Gran 
method.[4,7] After calibration, the system was prepared for the protonation studies by 
reacidifying the system with HCl and adding the right amount of ligand. After this first 
acid-base titration, the solution was acidified again and the right amount of metal was 
added in order to prepare the system for the complexation studies (Figure 3.2.). This 
procedure was used in order to optimise the consumption of the precious ligands. In each 
titration, the solution was brought from an approximate pH value of 2.3 to about pH 11.5 
(except in the case of earlier precipitation) by the addition of standard NaOH solution.  
 
 
 
 
Figure 3.2. Overall scheme of the chain acid-base titrations performed for each complex. 
 
 
3.2.3. Potentiometric acid-base titrations 
In potentiometry, the emf between two electrodes in contact with a solution is measured. 
This emf is affected by temperature and the species in solution, and is correlated to their 
activity. One of the electrodes is a reference one, which keeps its potential constant during 
the experiments. The other one is the indicator electrode, which has to be sensible towards 
the analyte of interest. Not always is possible to find an indicator electrode sensible 
towards the desired analyte but, fortunately, the system in equilibrium can usually be 
studied by following a competing species. For instance, in the case of the formation of a 
lanthanide complex, there will be competence between the H+ and lanthanide cations 
during the acid-base titration toward ligand complexation and, thus, it is possible to study 
the system by following the H+ cations instead of the lanthanide ones. As we have already 
mentioned, in this work a combined glass electrode has been used. It is both, the reference 
and the indicator electrode at the same time, and it is sensible towards the activity of H+ 
cations.  
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Both the additions and the measurements where controlled by a personal computer. The 
inputs which defined the data acquisition where: 
 
 
  ■ Total volume of NaOH injected during the experiment. 
  ■ Volume step (fix or variable) and number of lectures. 
  ■ Dead time after the injection, before the reading. 
  ■ Delay time between readings (same injection). 
  ■ Maximum drift accepted between readings (same injection). 
  ■ Maximum number of readings for the same injection.  
 
 
Titrations were performed on solutions containing the ligand (concentrations in the range 
0.6-1 mM, depending on the experiment; for complexation studies, also 1:1 metal in 
solution) and an excess of HCl .  
 
The emf data collected, the concentrations of the initial species (HCl, ligand and, 
eventually, metal), the initial volume, the temperature and the calibration data obtained 
previously are introduced in the Hyperquad program[8,9] in order to obtain the speciation 
model which better fits the experimental data. This program calculations are essentially 
based on a non-linear least-squares refinement, which minimizes the error (𝑈) in each 
run (𝑖) between calculated and experimental emf (𝐸), giving less weight (𝑤) to the data 
near the equivalence point (Equation 3.9.). 𝐸𝑐𝑎𝑙𝑐 is obtained from Equation 3.4.b, where 
the modified standard emf and a slope factor, used to correct the deviation from the 
expected slope, (𝑅𝑇𝑛𝐹) are obtained from the previous calibration. 
 
 
 𝑈 = ∑ [𝑤𝑖𝑖 (𝐸𝑐𝑎𝑙𝑐,𝑖 − 𝐸𝑒𝑥𝑝,𝑖)2]                      Equation 3.9. 
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3.2.4. Spectrophotometric acid-base titrations 
As already mentioned previously, potentiometic acid-base titrations are preferable for the 
study of systems in equilibrium due to its higher accuracy and precision. However, 
spectrophotometric acid-base titrations have been performed i) when the performance of 
potentiometric ones was not possible and ii) as a complementary technique for the 
acquisition of further information. 
 
The change in the UV-Vis absorbance of our analytes along the acid-base titrations is 
used for the study of its chemical equilibria. Equation 3.10. shows the most used 
mathematical representation of the Beer-Lambert Law which relates absorbance and 
analyte concentration, where 𝐴𝜆 is the absorbance at a certain 𝜆 wavelength, d is the path 
length of the fibre-optic probe, [S] is the concentration of the absorbing analyte S and 𝜀𝜆 the molar absorbance at a certain 𝜆 wavelength.[10] This expression can be used when 
working at low concentrations (< 0.02 M) and when the absorbing species does not go 
through chemical changes. 
 𝐴𝜆 = 𝑑 · [𝑆] · 𝜀𝜆                                         Equation 3.10. 
 
As our absorbent analytes form more than one absorbing species with diverse 
characteristic absorbance patterns during the experiments, the total absorbance of the 
system can be expressed as a sum of the separated contributions, as shown in Equation 
3.11., where n would be the number of different absorbing species formed. 
 
 
 𝐴𝜆 = 𝑑 · ([𝑆]0 · 𝜀𝜆,0 + [𝑆]1 · 𝜀𝜆,1 +··· +[𝑆]𝑛 · 𝜀𝜆,𝑛)               Equation 3.11. 
 
 
The wavelength range investigated depended on the chromophore moieties presented by 
the ligand. The cell contained the ligand (concentrations between 0.03 and 0.13 mM, 
depending on the experiment) and, in the case of complexation studies, also the metal 
(1:1 ratio).  
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The emf data and absorbances collected (related to specific added volumes), the 
concentrations of the initial species (HCl, ligand and, eventually, metal), the initial 
volume, the temperature and the calibration data obtained previously are introduced in 
the HypSpec[8,9,11]  program to obtain the speciation model which better fits the 
experimental data. Theoretically, the data obtained in one single wavelength (the one 
presenting the more marked change in absorbance during the titration) should be enough 
to perform the refinement, but it is better to pick some additional points around that 
chosen wavelength in order to reduce the effect of noise. However, it is advised to not 
use too many wavelengths.[9] Calculations are essentially based on a non-linear least-
squares refinement but, in this case, it minimizes the error (𝑈) in each run (𝑖) between 
calculated and experimental absorbance (𝐴) (Equation 3.12.).  
 
 𝑈 = ∑ (𝐴𝑐𝑎𝑙𝑐,𝑖−𝐴𝑒𝑥𝑝,𝑖𝐴𝑒𝑥𝑝,𝑖 )2𝑖                           Equation 3.12. 
 
 
3.2.5. Isothermal titration calorimetry 
Isothermal Titration Calorimetry (ITC) was performed in order to determinate the 
constants and the related complexation enthalpy (ΔH0) for the formation of the L-lactate 
(Lac) ternary complex with [Tb(rac-bpcd)]+. This technique has already been applied 
successfully to measure the heat involved in the species interaction.[12,13] The well-known 
thermodynamic equations 3.13. and 3.14. are used in order to get i) the free Gibbs energy 
(ΔG0) from K and ii) the entropy (ΔS0) from ΔH0 and ΔG0. 
 
 ΔG0 = −𝑅𝑇𝑙𝑛𝐾                                        Equation 3.13. 
 ΔG0 = ΔH0 − 𝑇ΔS0                                     Equation 3.14. 
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The [Tb(rac-bpcd)]+ complex solution was prepared by diluting together the stock 
solution of Tb and the H2bpcd ligand in its racemic form. The ITC experiment was carried 
out at 298.15 K with a TA instruments TAM III thermostat equipped with a 
nanocalorimeter and an automatic titration syringe. The Lac solution (25 injections of 10 
µL of Lac 80 mM) was added under constant stirring (60 rpm) to a 0.7 ml solution of 
[Tb(rac-bpcd)]+ (0.63 mM). The delay time between two consecutive injections was set 
to 12 min, which was long enough to let the system reach thermal equilibrium. The 
reference cell was filled with MilliQ water.  
 
 Q𝑐𝑜𝑟𝑟,𝑖,𝑛 = − ∑ (Δx𝑛)ΔH𝑛0𝑖                                      Equation 3.15. 
 
 
From this experiment we obtained the experimental heat (Qexp). The same experiment 
was repeated in absence of Lac in order to obtain the dilution heat (Qdil). The net reaction 
heat, or corrected heat (Qcorr), was obtained subtracting the Qdil to the Qexp. The 
experiment was repeated per triplicate to check the reproducibility of the data. The Qcorr 
data is directly correlated to the enthalpy, as presented in Equation 3.15., where Δx𝑛 is 
the change in the number of moles of the n species.  Qcorr and the experimental conditions 
were used as inputs for the Excel add-in cEST [14] (Section 3.5.2.) for the refinement of 
the formation constant of the ternary complex which better fit the experimental data.  
 
 
 
3.3. Luminescence 
3.3.1. Luminescence and decay kinetics 
Luminescence was measured at room temperature with a Fluorolog 3 spectrofluorometer 
(Horiba-Jobin Yvon) equipped with a single-emission monochromator (Model HR320), 
a Xe lamp, a double-excitation monochromator and a photomultiplier in photon counting 
mode for the detection of the emitted signal. All spectra were corrected for the spectral 
distortions of the setup.  
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A xenon microsecond flashlamp was used for decay kinetics measurements. The signal 
was recorded by a multichannel scaling method. True decay times were obtained using 
the convolution of the instrumental response function with an exponential function and 
the least-squares-sum-based fitting program (SpectraSolve software package). 
 
The total quantum yields (Φtot) were obtained by measuring the visible emission spectrum 
of a fluorescence quantum yield reference sample (quinine in 1N H2SO4) presenting  
Φtot = 54.6% and using the Equation 3.16., where Φ is the quantum yield, F the integrated 
emission area across the band, A the absorbance at the excitation wavelength and n the 
index of refraction of the solvent. The subscript u refers to the unknown and s to the 
standard.[15]  
 Φ𝑢 = 𝐴𝑠·𝐹𝑢·𝑛𝑢2𝐴𝑢·𝐹𝑠·𝑛𝑠2 · Φ𝑠                                      Equation 3.16. 
 
 
One of the methods used to find the association constants of the adducts between Ln(III) 
complexes and the target biomarkers is the use of the Benesi-Hildebrand equation 
(Equation 3.17.), by means of a double reciprocal plot: the intensity (or ratio between 
intensities of interest) is plotted versus either the inverse of the analyte concentration or 
the inverse of its square concentration. The most linear plot indicates the ratio between 
the complex and the analyte, being 1:1 for the former and 1:2 for the latter. The overall 
stability constant is calculated from the ratio intercept/slope.[16,17]  
 
 𝐼0(𝐼−𝐼0) = 𝐼0(𝐼∞−𝐼0) + 𝐼0{𝐾·(𝐼∞−𝐼0)·[𝐵𝑀]𝑛}                      Equation 3.17.a 
 
 
I0, I and I∞ are the emission intensities of Tb(III) at 546 nm in absence of analyte, 
intermediate analyte concentration and at concentration of complete complexation, 
respectively. K is the stability constant of the adduct, [BM] the concentration of the 
analyte (in our case, the target biomarker) and n the number of analyte molecules bound 
to the metal centre. 
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‘I’ can be substituted by ‘R’ when the ratio between two peaks (asymmetry ratio) is used. 
Also the MS Excel add-in cEST has been used for the refining of these constants (Section 
3.5.2.). 
 𝑅 = 𝐼( 𝐷5 0→ 𝐹7 2)𝐼( 𝐷5 0→ 𝐹7 0)                                       Equation 3.17.b 
 
 
The number of water molecules bound to the metal (q, hydration number) was determined 
using Horrock’s equation (Equation 3.18.a).[18,19] The A constant is 1.2 for Eu3+ and 5.0 
for Tb3+. τ is the radiative lifetime (lifetime of the radiation without non-radiative 
deactivation processes[20]) in water or heavy water. It is known that the X-H (i.e. X = N, 
O) oscillators nearby or in the first coordination sphere shorten luminescence lifetimes.[18] 
Thus, the correcting term 𝑄 (Equation 3.18.b)[18] is added to Horrock’s equation.  
 
 
 𝑞 = 𝐴 [ 1𝜏𝐻2𝑂 − 1𝜏𝐷2𝑂 − 𝑄]                              Equation 3.18.a 
 
 
 𝑄 =  ∑ (𝑄1 + 𝑄2 + ⋯ + 𝑄𝑛)𝑛                      Equation 3.18.b 
 
 
 
The radiative lifetimes have been obtained either by a) estimation by using Equation 
3.19.a (c = speed of light in vacuous, in cm/s; ?̃? = frequency of the transition in cm-1; n = 
refractive index of the medium, NA = Avogadro’s number; 𝜀(𝜐) = absorption spectrum of 
the transition in M-1cm-1; gn = degeneracy of the state (n = 0 for ground state, n = exc for 
the excited one) or b) calculation with Equation 3.19.b. Φ𝐿𝑛 is calculated either by using 
Equation 3.19.b or by using a reference standard.[21] The efficiency of the sensitization 
(ηsens) is calculated with Equation 3.19.c. 
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 1𝜏𝑟𝑎𝑑 = 2303 × 8𝜋𝑐𝑛2𝜐𝑢𝑙2𝑁𝐴 𝑔0𝑔𝑒𝑥𝑐 ∫ 𝜀(𝜐)𝑑𝜐                   Equation 3.19.a 
 Φ𝐿𝑛  = 𝜏𝑜𝑏𝑠𝜏𝑟𝑎𝑑                                   Equation 3.19.b 
 Φ𝑡𝑜𝑡  = η𝑠𝑒𝑛𝑠Φ𝐿𝑛                           Equation 3.19.c 
 
 
3.3.2. Circularly polarized light luminescence 
Circularly polarized light luminescence (CPL) spectra were recorded with a homemade 
spectrofluoropolarimeter.[22] In order to measure the efficiency of the CPL the 
dissymmetry factor (glum) is used (defined in Equation 3.20., where IL and IR are the left- 
and right-polarized intensities). 
 
 𝑔𝑙𝑢𝑚 = 2 (𝐼𝐿−𝐼𝑅)(𝐼𝐿+𝐼𝑅)                                    Equation 3.20. 
 
 
The spectra were recorded in water or deuterated methanol at 2.0−3.0 mM (for 
Tb(bpcd)Cl) or 8.0 mM (for Eu(bpcd)Cl) concentrations, under 254 nm irradiation using 
a 90° geometry between the excitation and the detection directions. It was verified that 
the racemates provided 0-signal over each spectral window investigated before carrying 
out the measurements on the single enantiomers. 
 
 
 
3.4. Characterization 
3.4.1. CHNOS-Elemental analysis 
Elemental analyses (EA) of the final products (ligands and complexes) and some of their 
intermediate products have been carried out by using a EACE 1110 CHNOS analyzer. 
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3.4.2. Electrospray ionization mass spectroscopy 
The final products (ligands and complexes) and some of their intermediate products have 
been also analysed by electrospray ionization mass spectrometry (ESI-MS) with a 
Finnigan LXQ Linear Ion Trap (Thermo Scientific, San Jose, CA, USA) operating in 
positive mode. Xcalibur software (Thermo Scientific) was used for the data acquisition. 
For the acquisition of the spectra, a methanol solution of the sample was diluted and 
infused with a syringe pump at a flow rate of 10 µL/min into the ion source. The typical 
source conditions were transfer line capillary at 275 °C; ion spray voltage at 4.70 kV; 
sheath, auxiliary and sweep gas (N2) flow rates at 10, 5 and 0 arbitrary units, respectively. 
Helium was used as the collision damping gas in the ion trap set at 1 mTorr. 
 
 
3.5. Data analysis and computational calculations 
3.5.1. Density functional theory 
Density functional theory (DFT) calculations have been used to obtain the most probable 
structures of the complexes discussed in this work.  
 
It is rather difficult to model Eu(III) and Tb(III) complexes computationally due to their 
open-shell electronic configuration. Thus, Y(III) analogues have been used in the DFT 
calculations for the complexes discussed in this work. The substitution of Eu(III) and 
Tb(III) by Y(III) in DFT computational studies has been proved to be a suitable 
approximation,[23] which is consistent with the fact that ionic radii of  Y3+, Eu3+ and Tb3+ 
are very similar (Table 1.5.) due to the lanthanide contraction.[24] Vibrational analysis was 
used to check all final geometries were minima. Solvent effects were considered by using 
the PCM model. Calculations have been carried out by using either Gaussian09 or 
Gaussian16.[25,26]  
 
3.5.2. cEST and Solverstat 
Equilibrium speciation tool (cEST)[14] is an Excel add-in for the simulation of chemical 
equilibria in solution. This software calculates the concentrations in equilibrium of 
species in non-aqueous and aqueous systems. It can be used for complexation, acid-base, 
redox and solubility equilibria. It can simulate or obtain chemical-physical parameters 
from experimental data (even heats from calorimetry experiments). The computational 
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methods developed in cEST are shown to be very reliable also when applied to 
homogeneous or heterogeneous equilibrium systems.[27,28] 
 
The statistical analysis of the result is a crucial step to evaluate the reliability of the 
models. SolverStat[29] is an Excel add-in that performs advanced statistical tests on least 
squares regression data. Unlikely the Excel add-in Solver, SolverStat provides estimates 
of the precision of the fitted parameters and a complete and prompted analysis of fittings.  
 
These Excel add-in have been used in this work for the fitting of the formation constants 
of some Ln(III) complexes with lactate, bicarbonate and citrate and for their statistical 
analysis. The refinement of the data has been achieved by minimizing the sum of the 
squares differences between the experimental and the calculated data (area of the selected 
luminescence peaks or asymmetry ratio, more details in Section 3.3.). In order to decide 
the most reliable model, some statistic parameters have been taken into account; the best 
model for each system should present the lowest confidence interval (obtained from the 
standard deviation of the refined constants, 95% confidence) and Akaike Information 
Criteria Corrected (AICc)[30]. The AICc parameter is a correction of the AIC parameter 
for small populations (<10) and is based on the least-squares approach. It permits 
comparison between models, being the model presenting a lower AICc (or AIC) value 
considered better. 
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Chapter 4 
Complexation and protonation 
 
 
4.1. Library of ligands and complexes 
When designing Ln(III) complexes for biomedical applications it is fundamental to find 
an adequate ligand. It has to strongly absorb the exciting UV-Vis light and efficiently 
transfer it to the Ln(III) ion (antenna effect, refer to Chapter 1). Moreover, it has to be 
stable in water (biocompatibility) and should present a high overall brightness, as well as 
leaving some space for the coordination of additional target molecules (i.e. biomarkers).  
 
We have already discussed in Chapter 1 that Polyamino-polycarboxylate ligands are great 
candidates for the formation of highly stable Ln(III) complexes, which makes them 
specially suitable for biomedical applications.[1–4] 
 
The ligand should also present a chromophore moiety (antenna group).[5–7] In literature 
we can find several examples of luminescent Ln(III) complexes presenting amino 
heteroaromatic antenna, such as pyridine[8–13], quinoline[14,15], isoquinoline[2] and 
acridone[16–18]. Also the preorientation of a favorable geometry generated by rigidity and 
steric constrains may increase the overall binding affinity.[11] 
 
In this study we propose some Ln(III) (Ln = Eu, Tb) polyamino-polycarboxilate 
complexes of ligands with either pyridine or quinoline chromophore moieties (antenna) 
(Figure 4.1.). All the ligands present a 1,2-diaminocyclohexane backbone (DACH, Figure 
4.1.) which confers them both, rigidity and chirality.  
 
The complexes formed with these four ligands differ in charge, steric hindrance and 
lipophilicity since i) Ln(PyC3A) and Ln(QC3A) are neutral, while Ln(bpcd)+ and 
Ln(bQcd)+ are cationic; ii) each complex presents diverse steric hindrance at the metallic 
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This modulation of the DACH backbone by functionalizing it with diverse moieties will 
facilitate the study of the selectivity towards diverse target analytes, as previously stated 
in literature,[21,22] since we expect steric hindrance and charge to strongly influence the 
stability of both the Ln(III) complexes and their adducts with the target biomarkers (as 
already discussed in Chapter 1). Moreover, all the presented complexes show less steric 
hindrance around the metal center in comparison with other luminescent Ln(III) anion 
probes found in literature. This might facilitate the coordination of more than one target 
anion to the first coordination sphere, which would lead to a higher affinity between the 
complex and the target biomarker. 
 
 
4.2. Stability, speciation and structure 
4.2.1. Protonation constants  
The protonation constants of the ligands used during this work have been determined by 
acid-base potentiometric titration. The best fit of the experimental emf data for all ligands 
was reached with the Hyperquad program by using a four species model. For more 
experimental details, refer to Chapter 3. 
 
The constants obtained are reported in Table 4.1. along with additional protonation data 
from literature for the ligand PyC3A and 1,2-cyclohexanediaminetetraacetic acid (CDTA, 
Figure 4.3.), which also presents the DACH backbone. The titration curve for all the 
ligands is displayed in Figure 4.2. along with its speciation, calculated with the Hyss 
program[23] by using the experimental conditions and the protonation constants found. In 
this figure we observe very similar trends in speciation for all the ligands, with two clear 
inflection points at 2 and 3 equivalents of free OH- and concurring with the maximum 
concentration for the species LH2 and LH respectively. The logK values reported indicate 
the presence of two fairly strong acidic and two weakly basic sites in each ligand. Even 
if the ligands present six groups presenting acid/base properties, the protonation constants 
of the two remaining groups could not be determined, as they did not present acid/base 
activity in the pH range of study. As previously reported for CDTA[24], the first 
protonation constant can be assigned for all the ligands to an aliphatic amine group (logK ∼6.9 - 10.7, depending on the substituents[25]).  
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Table 4.1. Protonation constants (logKi) of all the ligands used in this work (Figure 4.1.), with their 
confidence intervals (95% confidence), found by potentiometry at T = 298.2 K ± 0.1 K and μ = 0.1 M 
NaCl. Additional protonation data from another work (μ = 0.15 M NaCl) has also been reported for 
comparison. Charges omitted for clarity. 
 bpcd bQcd PyC3A QC3A PyC3A[26] CDTA[26] 
logK1 9.72 ± 0.02 9.37 ± 0.03 10.26 ± 0.02 10.53 ± 0.03 10.16 ± 0.02 9.43 ± 0.02 
logK2 5.87 ± 0.07 5.85 ± 0.07 6.33 ± 0.07 6.29 ± 0.09 6.39 ± 0.04 6.01 ± 0.02 
logK3 2.94 ± 0.12 3.46 ± 0.10 3.67 ± 0.11 3.60 ± 0.16 3.13 ± 0.03 3.68 ± 0.02 
logK4 2.22 ± 0.17 1.79 ± 0.31 2.01 ± 0.14 2.81 ± 0.16 - 2.51 ± 0.05 
 
 
 
Figure 4.2. Titration curve ( observed and  calculated pH) for the ligand (L) a) bpcd (0.95 mM), b) 
bQcd (0.94 mM), c) PyC3A (0.6 mM) and d) QC3A (0.7 mM) obtained by acid-base potentiometric titration 
at T = 298.2 K ± 0.1K and μ=0.1 M NaCl. a = (moles of free OH-) / (moles of L). Charges omitted for 
clarity. 
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Figure 4.3. From left to right, ligands bped [27], PEDTA[28], EDTA[29] and CDTA[24]. 
 
 
 
Further data were needed to assign the other protonation constants to specific sites. Thus, 
acid-base spectrophotometric titrations were performed in the same conditions of the 
protonation titrations in order to follow the deprotonation of the pyridine and quinoline 
moieties during the titration. The protonation of the nitrogen present in pyridine and 
quinoline moieties increases the molar absorbance of the ligand, which permits the 
assignation of some protonation constants to the protonation of the heterocycles. The 
molar absorbances obtained (at λ = 265 nm for pyridine-functionalized and at λ = 318nm 
for quinoline-functionalized ligands are reported in Figure 4.4. along with the speciation 
calculated with the Hyss program[23] by using the experimental conditions and the 
protonation constants found. By observing the trends of molar absorbance and speciation 
together, we may assign the K3 constants of the triacetate ligands and all K2 constants to 
the protonation of the heterocyclic nitrogen. This is in agreement with the protonation 
constants found in literature for quinoline (logK = 4.97)[30] and picoline (logK = 6.06)[31]. 
The remaining protonation constants may be assigned to the protonation of acetates. The 
protonation sequence we propose is in agreement with the one suggested by Caravan[27] 
for bped (Figure 4.3.), a ligand similar to bpcd but with an ethylene substituting the 
DACH backbone.  
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Figure 4.5. UV-Vis absorption spectra changes during the acid-base titration (in the pH range 2.3-11.5) 
for the ligands a) PyC3A (0.13 mM) and b) QC3A (0.09 mM), in the presence of equimolar Eu(III). T = 
298.2 K and μ = 0.1 M NaCl.    
 
 
* µ = 0.16 M NaCl 
 
 
If we check the stability constants presented in Table 4.2., it can be observed that 
complexes with quinoline moieties (bQcd and QC3A) present lower stability constants 
than their pyridine analogues (bpcd and PyC3A respectively). This behavior is not 
surprising, since bulkier quinoline moieties cause stronger steric hindrance than pyridine 
ones.  
 
 
Table 4.2. Stepwise formation constants (logβ) of all the complexes discussed in this work with 
their confidence intervals (95% confidence), found by acid-base titration at  
T = 298.2 K ± 0.1 K and μ = 0.1 M NaCl. Other similar complexes have also been reported for 
comparison. Charges omitted for clarity. 
 bpcd bQcd PyC3A QC3A bped[27] PEDTA[28] EDTA[29] CDTA[29] 
Eu(III)L 11.19 
± 0.32 
9.97 
± 0.08 
15.68 
± 0.01 
12.55 
± 0.16 
- - 17.3 19.6 
Eu(III)L(OH) 2.18 
± 0.57 
- - - - - - - 
Tb(III)L 11.36 
± 0.15 
9.80 
± 0.13 
15.70 
± 0.02 
12.08 
± 0.28 
- - 17.9 20.0 
Tb(III)L(OH) 2.04 
± 0.33 
- - - - - - - 
Gd(III)L - - - - 12.37* 15.56 17.4 19.6 
Gd(III)L(OH) - - - - 2.1* - - - 
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On the other hand, triacetate complexes (PyC3A and QC3A) present higher stability 
constants than their diacetate analogues (bpcd and bQcd respectively). This trend can be 
easily explained by the noted strong interaction between oxygen donors and Ln(III), and 
is also observed for the similar ligands bped[27], PEDTA[28] and EDTA[29] 
(bi- , tri- and tetra-acetate respectively) with Gd(III), and for the tetra-acetate CDTA[29] 
(Figure 4.3.), which presents the highest stability constants for Eu(III), Tb(III) and 
Gd(III). Besides, as expected and currently observed in literature[29], the stability of the 
Eu(III) and Tb(III) complexes with the same ligand are analogous, due to the very similar 
radii properties among this close Ln(III).[7] 
 
The species distribution of the ligands bpcd, bQcd, QC3A and PyC3A in water in the 
presence of Eu(III) or Tb(III) at 298.2 K has been calculated with the program Hyss[23] 
by using the found protonation and stability constants. The speciations are represented in 
Figure 4.6. along with the molar absorbances from pH 2 to 11. We can observe that, in 
all cases, the luminescent L-Ln(III) species is the most abundant species at pH around 
7.4, representing near the 100% of the total L species at that pH. We can also observe that 
the molar absorbance decreases with the formation of the Ln(III) complex. Since molar 
absorbance is higher for the protonated heteroaromatic antenna, we may assume the 
coordination of Ln(III) with the heterocyclic nitrogen/s. 
 
 
4.2.3. Structure 
It was not possible to obtain single crystals suitable for X-ray diffraction from our Ln(III) 
complexes, thus their structure was studied by density functional theory (DFT) 
calculations. As we have already discussed in Chapter 3, this computational method has 
been previously applied successfully to obtain structural and thermochemical data for f-
block metal complexes.[32–34] It is very difficult to fit the models for Eu(III) and Tb(III) 
complexes since these metals are paramagnetic. Thus, the Y(III) analogue has been used 
instead, as the radii of Eu(III) (94.7 pm), Tb(III) (92.3 pm) and Y(III) (90.0 pm) are quite 
similar due to the lanthanide contraction.[7,8,10,35] 
 
An 8-fold coordination was obtained for all the Y(III) complexes (including water 
molecules). Moreover, an equilibrium between two isomers in solution was found in all 
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cases, with trans-N,N and trans-O,O structures for the cationic diacetate complexes ([Ln-
bpcd]+ and [Ln-bQcd]+) and trans-O,O and trans-N,O structures for the neutral triacetate 
ones (Ln-PyC3A and Ln-QC3A), all of them presenting two water molecules in the first 
coordination sphere (Figure 4.7.). Comparable geometries have been previously seen in 
literature for analogous complexes, such as Gd(III)-bpcd[36], M(III)-bped[27] (M = Al, Ga, 
In) and other similar complexes[37].  
 
Unfortunately, it was not possible to confirm these structures via nuclear magnetic 
resonance (NMR), as the spectra of the complexes present hardly-assignable broad 
resonances. The wide lines obtained are in agreement with the proposed solution 
equilibria between isomers. We present one of the NMR spectrum in Figure 4.8. as a 
representative example.  
 
If we go back to Figure 4.6., we said that the contemporaneous decreasing in the molar 
absorbance and formation of the Ln(III) complex may indicate the coordination of Ln(III) 
with the heterocyclic nitrogen/s, which is in accordance with the structures proposed. 
Moreover, the number of water molecules close to the metal (hydration number, Table 
3.4.) was also determined by luminescent experiments and using Horrock’s equation 
(Equation 3.18.a),[38,39] where q is the hydration number and τ are the radiative lifetimes 
in water and heavy water (Section 3.3.1.). The obtained values (from 2.4 to 2.8) are 
partially in accordance with the structures proposed by DFT calculations. But it has to be 
emphasized that i) Horrock’s equation usually overestimates the number of waters 
directly coordinated to the metal, as also outer sphere waters are slightly considered[39] 
and ii) the structures proposed by DFT calculations may also be in equilibrium with 
analogous structures presenting three waters, as additional water molecules where also 
assessed in the second coordination sphere near the metal centre (Figure 4.9). 
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[Y(trans-O,O-bpcd)(H2O)2]+ [Y(trans-O,O-PyC3A)(H2O)2]+ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[Y(trans-N,N-bpcd)(H2O)2]+ [Y(trans-N,O-PyC3A)(H2O)2]+ 
 
 
 
 
 
 
 
 
 
 
 
 
[Y(trans-O,O-bQcd)(H2O)2]+ [Y(trans-O,O-QC3A)(H2O)2]+ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[Y(trans-N,N-bQcd)(H2O)2]+ [Y(trans-N,O-QC3A)(H2O)2]+ 
  
 
Figure 4.8. Minimum energy structures found for the Y(III) complexes by DFT calculations. 
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Figure 4.7. 1H-NMR spectrum (600MHz, CD3OD) of the Tb(bpcd)Cl complex. 
 
 
The Y-Nheterocyclic distances found for pyridine-based complexes are shorter than those 
found for the quinoline-based ones (Table 4.3.), which is in accordance with the higher 
stability constants found for the pyridine-based complexes (Table 4.2.). 
 
 
 
 
Table 4.3. Representative bond distances (Å) found by DFT calculations for the complexes 
represented in Figure 4.7.. 
Complex Y-Oacetate Y-Namine Y-Nheterocycle Y-Owater 
[Y(trans-O,O bpcd)(H2O)2]+ 2.262 2.550 2.525 2.448 
[Y(trans-N,N bpcd)(H2O)2]+ 2.292 2.610 2.503 2.492 
[Y(trans-O,O bpcd)(H2O)2]+ 2.268 2.557 2.661 2.464 
[Y(trans-N,N bpcd)(H2O)2]+ 2.284 2.567 2.594 2.482 
Y(trans-O,O PyC3A)(H2O)2 2.286 2.568 2.550 2.474 
Y(trans-N,O PyC3A)(H2O)2 2.300 2595 2.546 2.539 
Y(trans-O,O QC3A)(H2O)2 2.286 2.574 2.654 2.458 
Y(trans-N,O QC3A)(H2O)2 2.290 2.576 2.642 2.478 
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[Y(trans-O,O-bQcd)(H2O)5]+ [Y(trans-N,N -bQcd)(H2O)5]+ 
 
 
 
 
[Y(trans-O,O-PyC3A)(H2O)3] [Y(trans-O,O-QC3A)(H2O)3] 
 
Figure 4.9. Minimum energy structures found for the Y(III) complexes 
by DFT calculations including 2nd sphere water molecules 
 
 
4.2.4. Luminescent characterization 
The excitation spectra in aqueous solution for the Eu(III) complexes with bpcd2-, 
bQcd2-, PyC3A3- and QC3A3-, and the Tb(III) complex with PyC3A3- are shown in 
Figures 4.10.a-b, left part of the graphs. For Eu complexes, the 5D0→7F2 transition of 
Eu(III) has been monitored (λem = 612-615 nm); for Tb complexes, the 5D4→7F5 transition 
of Tb(III) has been monitored (λem = 545 nm).  
 
The ligand to metal energy transfer is confirmed when the excitation spectra and their 
equivalent absorption ones (Figure 4.11.) are superimposable.  In the absorption graph, 
we may also notice that the spectra for complexes presenting the same kind of antenna 
moiety (either, pyridine or quinoline) are also superimposable, and the complexes 
presenting two antenna moieties show, as expected, nearly double of the molar 
absorbance than their one-antenna equivalents.  
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Table 4.4. Observed lifetimes (τobs), in either water or heavy water; radiative lifetimes (τrad), 
estimated or *calculated with Equation 3.4.b; hydration number (q); intrinsic quantum yield 
(ΦLn), estimated in water using Equation 3.4.b or **determined by means of a reference 
standard; total quantum yield (Φtot) and sensitization (ηsens) of the Eu(III) and Tb(III) 
complexes under study. 
Complex τobs (ms) τrad (ms) q ΦLn (%) Φtot (%) ηsens 
(%) 
 H2O D2O      
[Eu(bpcd)]+ 0.30 ± 0.01 1.70  ± 0.01 3.00 2.7  ± 0.1 10.0 6.1 61 
[Eu(bQcd)]+ 0.29 ± 0.01 1.68  ± 0.01 3.22 2.8  ± 0.1 9.0 2.6 29 
Eu(PyC3A) 0.33 ± 0.01 3.56  ± 0.01 3.66 2.7 ± 0.1 9.0 5.67 63 
Eu(QC3A) 0.33 ± 0.01 2.15  ± 0.01 3.34 2.5 ± 0.1 9.9 4.0 40 
[Tb(bpcd)]+ 0.94 ± 0.01 2.15  ± 0.01 5.98* 2.6 ± 0.1 15.7** 10.0 64 
Tb(PyC3A) 1.16 ± 0.01 3.53  ± 0.01 6.86* 2.4 ± 0.1 16.9** 11.2 66 
 
Φtot is the ratio between the photons emitted by the Ln(III) and the ones absorbed by the 
ligand. It is calculated by means of a reference standard presenting a known Φ (refer to 
Section 3.3.1. for experimental details). The apparently low Φtot values are in fact in a 
range typically seen in literature for cell imaging with either lanthanide or d-block 
complexes (4-10% range)[19,41–44]. Moreover, we are expecting a rise in this value with 
the formation of the adduct with the target biomarker, since the quenching water 
molecules in the inner sphere will be displaced. 
 
The ηsens value is calculated by using Equation 3.4.c. As it can be seen in Table 4.4., it 
results much higher for the pyridine-functionalized complexes (61-66%) than for the 
quinoline-functionalized ones (29-40%). This may be attributed to the shorter Ln-
Nheterocycle distances in the case of quinoline-based complexes (DFT calculations), since 
the energy transfer from the antenna to the Ln(III) depends on the distance between them: 
the shorter is the distance, the more efficient is the energy transfer and, consequently, the 
higher is ηsens.[45] 
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4.3. Conclusions 
  
 
 
 
PROTONATION OF THE LIGANDS 
 
■  
 
The proposed ligands are stable in water at the studied pH range (from 2 to 11), 
temperature (298 K) and ionic strength (0.1 M NaCl).  
 
■ The protonation constants obtained are in accordance with values found in 
literature for similar ligands and conditions. 
 
■ They all present four dissociable protons assigned to either acetate, 
heteroaromatic nitrogen or ternary nitrogen positions. 
 
 
FORMATION OF THE COMPLEXES 
 
■ The Eu(III) and Tb(III) complexes studied are very stable at the proposed pH 
range (from 2 to 11), temperature (298 K) and ionic strength (0.1 M NaCl). 
 
■ The overall stability constants found are high and in accordance with values 
found in literature for similar complexes and conditions. 
 
■ The pyridine-functionalized ligands present higher affinity for the lanthanide 
cations due to the higher steric hindrance of the bulkier quinoline moieties. 
 
■ The tri-acetate ligands form more stable lanthanide complexes than the di-
acetate ones due to the higher negative charge of the former ones and the 
oxyfilicity of lanthanide cations. 
 
■ The predominant species in solution at pH 7.4 is in all cases the luminescent 
lanthanide complex, with around 100% prevalence.  
 
■ All complexes are octacoordinated, presenting 2 waters in the first 
coordination sphere. The presence of these coordinated waters, which quench 
the luminescent signal, can be substituted by the target biomarker, which 
would cause a rising in the luminescent response. 
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LUMINESCENCE OF THE COMPLEXES 
 
■ Eu(III) is sensitized by all the ligands in study. On the other hand, Tb(III) is 
sensitized just by the ligands presenting pyridine antenna. 
 
■ The 1:1 ligand-Ln(III) stoichiometry is confirmed by the fitting of the 
luminescent decay curves in single exponential functions. 
 
■ Less multiphonon relaxation is observed in Tb(III) complexes due to smaller 
energy gaps between excited and ground levels. 
 
■ Total quantum yields are in the range of values frequently found in literature 
for cell imaging with either lanthanide or d-block complexes. Moreover we 
expect the rise of these values due to the substitution of the quenching 
coordinated waters by the target biomarker. 
 
■ ηsens are higher for pyridine- (61-66%) than for quinoline-based (29-40%) 
complexes, which may be attributed to the longer Ln(III)-Nheterocyclic bonds in 
the latter ones (DFT). 
Chapter 4 
 
63 
 
4.4. Bibliography 
[1] R. Janicki, A. Mondry, P. Starynowicz, Coord. Chem. Rev. 2017, 340, 98–133. 
[2] F. Caillé, C. S. Bonnet, F. Buron, S. Villette, L. Helm, S. Petoud, F. Suzenet, É. Tóth, 
Inorg. Chem. 2012, 51, 2522–2532. 
[3] J. M. Couchet, J. Azéma, C. Galaup, C. Picard, J. Lumin. 2011, 131, 2735–2745. 
[4] E. Brunet, O. Juanes, R. Sedano, J. C. Rodríguez-Ubis, Tetrahedron Lett. 2007, 48, 
1091–1094. 
[5] C. Picard, N. Geum, I. Nasso, B. Mestre, P. Tisnès, S. Laurent, R. N. Muller, L. Vander 
Elst, Bioorganic Med. Chem. Lett. 2006, 16, 5309–5312. 
[6] M. H. V. Werts, Sci. Prog. 2005, 88, 101–131. 
[7] S. Cotton, Lanthanide and Actinide Chemistry, John Wiley & Sons, Ltd, 2006. 
[8] M. Leonzio, A. Melchior, G. Faura, M. Tolazzi, M. Bettinelli, F. Zinna, L. Arrico, L. Di 
Bari, F. Piccinelli, New J. Chem. 2018, 42, 7931–7939. 
[9] C. C. McLauchlan, J. Florián, D. S. Kissel, A. W. Herlinger, Inorg. Chem. 2017, 56, 
3556–3567. 
[10] M. Leonzio, A. Melchior, G. Faura, M. Tolazzi, F. Zinna, L. Di Bari, F. Piccinelli, Inorg. 
Chem. 2017, 56, 4413–4422. 
[11] M. D. Ogden, S. I. Sinkov, G. P. Meier, G. J. Lumetta, K. L. Nash, J. Solution Chem. 
2012, 41, 2138–2153. 
[12] N. Chatterton, C. Gateau, M. Mazzanti, J. Pécaut, A. Borel, L. Helm, A. Merbach, 
Dalton Trans. 2005, 1129–1135. 
[13] P. Caravan, P. Mehrkhodavandi, C. Orvig, 1997, 1669, 1316–1321. 
[14] C. M. G. dos Santos, A. J. Harte, S. J. Quinn, T. Gunnlaugsson, Coord. Chem. Rev. 
2008, 252, 2512–2527. 
[15] J. P. Leonard, T. Gunnlaugsson, J. Fluoresc. 2005, 15, 585–595. 
[16] X. Wang, H. Chang, J. Xie, B. Zhao, B. Liu, S. Xu, W. Pei, N. Ren, L. Huang, W. 
Huang, Coord. Chem. Rev. 2014, 273–274, 201–212. 
[17] Y. Bretonniere, M. J. Cann, D. Parker, R. Slater, Org. Biomol. Chem. 2004, 2, 1624–
1632. 
[18] Y. Bretonnière, M. J. Cann, D. Parker, R. Slater, Chem. Commun. 2002, 8, 1930–1931. 
[19] K. L. Peterson, J. V. Dang, E. A. Weitz, C. Lewandowski, V. C. Pierre, Inorg. Chem. 
2014, 53, 6013–6021. 
[20] B. S. Murray, E. J. New, R. Pal, D. Parker, Org. Biomol. Chem. 2008, 6, 2085–2094. 
[21] D. G. Smith, R. Pal, D. Parker, Chem. - A Eur. J. 2012, 18, 11604–11613. 
[22] C. P. Montgomery, E. J. New, D. Parker, R. D. Peacock, Chem. Commun. 2008, 4261–
4263. 
Chapter 4  
 
64 
 
[23] L. Alderighi, P. Gans, A. Ienco, D. Peters, A. Sabatini, A. Vacca, Coord. Chem. Rev. 
1999, 184, 311–318. 
[24] R. Ferreirós-Martínez, D. Esteban-Gómez, C. Platas-Iglesias, A. de Blas, T. Rodríguez-
Blas, Dalton Trans. 2008, 5754–65. 
[25] A. V. Rayer, K. Z. Sumon, L. Jaffari, A. Henni, J. Chem. Eng. Data 2014, 59, 3805–
3813. 
[26] E. M. Gale, S. Mukherjee, C. Liu, G. S. Loving, P. Caravan, Inorg. Chem. 2014, 53, 
10748–10761. 
[27] P. Caravan, S. J. Rettig, C. Orvig, Inorg. Chem. 1997, 36, 1306–1315. 
[28] M. Wagner, R. Ruloff, E. Hoyer, W. Gründer, Z.Naturforsch. 1997, 52c, 508–515. 
[29] R. M. Smith, A. E. Martell, Sci. Total Environ. 1987, 64, 125–147. 
[30] G. Anderegg, Helv. Chim. Acta 1974, 57, 1340–1346. 
[31] K. Kahmann, H. Sigel, H. Erlenmeyer, Helv. Chim. Acta 1964, 47, 1754–1763. 
[32] A. C. Mendonça, A. F. Martins, A. Melchior, S. M. Marques, S. Chaves, S. Villette, S. 
Petoud, P. L. Zanonato, M. Tolazzi, C. S. Bonnet, et al., Dalt. Trans. 2013, 42, 6046. 
[33] F. Endrizzi, A. Melchior, M. Tolazzi, L. Rao, Dalton Trans. 2015, 44, 13763–14180. 
[34] F. Piccinelli, M. Bettinelli, A. Melchior, C. Grazioli, M. Tolazzi, Dalt. Trans. 2015, 44, 
182–192. 
[35] M. Soulié, F. Latzko, E. Bourrier, V. Placide, S. J. Butler, R. Pal, J. W. Walton, P. L. 
Baldeck, B. Le Guennic, C. Andraud, et al., Chem. - A Eur. J. 2014, 20, 8636–8646. 
[36] J. Florián, C. C. McLauchlan, D. S. Kissel, C. C. Eichman, A. W. Herlinger, Inorg. 
Chem. 2015, 54, 10361–10370. 
[37] G. Tircsó, M. Regueiro-Figueroa, V. Nagy, Z. Garda, T. Garai, F. K. Kálmán, D. 
Esteban-Gómez, É. Tóth, C. Platas-Iglesias, Chem. - A Eur. J. 2016, 22, 896–901. 
[38] W. D. W. Horrocks, D. R. Sudnick, J. Am. Chem. Soc. 1979, 101, 334–340. 
[39] R. M. Supkowski, W. D. W. Horrocks, Inorg. Chim. Acta 2002, 340, 44–48. 
[40] M. Mihorianu, M. Leonzio, M. Monari, L. Ravotto, P. Ceroni, M. Bettinelli, F. 
Piccinelli, ChemistrySelect 2016, 1, 1996–2003. 
[41] M. Chen, Y. Wu, Y. Liu, H. Yang, Q. Zhao, F. Li, Biomaterials 2014, 35, 8748–8755. 
[42] C. Li, Y. Liu, Y. Wu, Y. Sun, F. Li, Biomaterials 2013, 34, 1223–1234. 
[43] S. P. Y. Li, A. M. H. Yip, H. W. Liu, K. K. W. Lo, Biomaterials 2016, 103, 305–313. 
[44] D. Parker, P. K. Senanayake, J. A. Gareth Williams, J. Chem. Soc. Perkin Trans. 2 1998, 
2129–2140. 
[45] D. L. Dexter, J. Chem. Phys. 1953, 21, 836–850. 
 
Chapter 5 
 
65 
 
 
Chapter 5 
Luminescent sensing of relevant 
biomarkers 
 
 
5.1. Background: sensing of biomarkers 
As already discussed in Chapter 1, luminescent Ln(III) complexes have been broadly used 
for sensing due to their exceptional optical properties, which make them potentially more 
interesting than other probe concepts. We have also briefly presented the high variety of 
target ions and molecules which may be sensed by this complexes, from small anions 
such as chlorides to big molecules such as proteins. In this chapter we will evaluate the 
viability of the lanthanide complexes presented in Chapter 4 as luminescent sensors for 
some crucial anionic biomarkers (L-lactate, bicarbonate and citrate). We will discuss their 
affinity with the target analytes, the structure of the adducts and their luminescent 
response. We will also discuss their potential as bioprobes for practical applications in 
terms of selectivity and mobility/localization in the organism. 
 
 
5.2. Lactate sensing 
5.2.1. Introduction 
Lactic acid (Figure 5.1.) is a weak acid with a pKa of 3.69 at 298.15 K and an ionic 
strength (µ) of 0.1 M in water[1]. This pKa is much lower than that of cells and extracellular 
fluids (physiologic pH is around 7.4, and the lowest limits of pH compatible with life over 
a prolonged period is 6.8). If we use the Henderson-Hasselbalch equation (Equation 5.1.), 
we can easily calculate the approximated ratio lactate/lactic acid expected under 
physiological pH (Equation 5.2.a) and critically low pH (Equation 5.2.b). Regarding the 
high ratios obtained in this calculations (over 800) we can state that mostly all lactic acid 
will be in the form of lactate in physiological conditions.[2] Thus, in lactic acid/lactate 
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studies for biomedical applications, the lactate form will be considered (more specifically, 
L-lactate[3], figure 5.1. left). 
 
 
 
 
Figure 5.1. L-lactic acid (left) and D-lactic acid (right). 
 
 
pH = pKa + log ([A-]/[HA])                                      (Equation 5.1.) 
 
 
7.4 = 3.85 + log ( [lactate] / [lactic acid] )  3548:1                    (Equation 5.2.a) 
6.8 =  3.85 + log ( [lactate] / [lactic acid] )  891:1                     (Equation 5.2.b) 
 
 
Hyperlactatemia (excess of lactate, check usual lactate concentrations in diverse 
physiological fluids in Table 5.1.) is related to an increase in the anaerobic metabolism, 
which may be caused by extensive physical exercise or by several pathological 
conditions, such as respiratory, renal or liver failure.[2,4] The detection and monitoring of 
lactate concentration has indeed become of great importance due to its crucial role in 
many fields such as sports medicine (i.e. brain function during exercise and lactate 
threshold)[3,6,7], food industry (i.e. microbial contamination and food adulteration)[8] and 
clinical diagnostics (i.e. liver and respiratory failure, sepsis, Parkinson’s disease, prostate 
cancer and colon cancer)[2,3,5,9–12]. Thus, high lactate concentration (>4.0 mM) is 
prognostic in prehospital, emergency departments and intensive care unit settings, as it 
may act as an alarm signal for the diagnosis of patient conditions, and can be used to 
guide early resuscitation therapy in critical situations.[2,3,13]  
 
During the last decades many lactate sensors have been developed. Currently, the 
predominant lactate sensors in the market are electrochemical, as they are user-friendly, 
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sensitive, economic and portable, but they do not permit the convenient monitoring of the 
lactate concentration through time, as the implanted sensors get coated by body defense 
mechanisms. Implanted biosensors have been tested with no commercial success due to 
biocompatibility issues.[3] For instance, vascular sensors may cause thrombosis or 
embolism.[14] Many attempts have been made to monitor lactate in other fluids/tissues. 
To do so, it is important to choose matrices whose lactate content correlates with its 
concentration in blood (Table 5.1.).[3] As an example, an electrochemical non-invasive 
sensor has been developed for the quantification of lactate in exhaled breath, with a low 
detection limit of 150 nM and good selectivity toward common interferences in this 
matrix, but no validation with real samples was reported.[15]  
 
 
Optical lactate sensors have also been developed from the 60’s. In 1964, an absorbance-
based sensor (and the first optical sensor developed for lactate detection reported in 
literature) was developed by Broder and Weil.[13] But absorbance techniques were 
gradually replaced by fluorescence techniques, due to their independence from the light 
pathway and their lower detection limits.[3] Conveniently, the luminescence intensity of 
the luminescent substances is usually correlated to their concentration. Thus, many 
fluorescent sensors have been developed for the detection of lactate. For instance, Groegel 
et al. reported in 2011 an enzymatic biosensor capable of detecting L-lactate with a 
detection limit of 164 nM,[19]  
 
Even if there already exist some commercial sensors for the determination of lactate at 
abnormally-high concentrations, the achievement of miniaturizable, more robust, and 
more selective probes is still a challenge.[4] Luminescent sensors may permit the 
development of valuable non-invasive and miniaturized sensors, which would lead to the 
commercialization of biocompatible lactate sensors with the capability of constantly 
monitoring the concentration of this relevant biomarker. 
 
Table 5.1. Amount of lactate found in different body fluids.[3][16] 
MATRIX Blood 
Extracellular  
fluid 
Intracellular 
fluid 
Tears 
Exhaled 
breath 
Saliva 
[Lactate] 
(mM) 
0.5-2* 0.6-2.3 3-22 1-5 0.014-0.022 0.1-2.5 
* It may be higher during exercise (12 mM)[17] or extreme exercise (25 mM)[18]. 
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5.2.2. Stability 
The stability constants (Table 5.2.) for the adduct between [Tb(bpcd)]+ and L-lactate 
(from now on Lac) has been determined via two independent experiments: luminescent 
titration (LT, Figure 5.2.) and isothermal titration calorimetry (ITC, Figure 5.3.). For 
experimental and calculation details, please refer to Chapter 2. The data from LT 
experiments were processed by using the Benesi-Hildebrand equation (Section 3.3.1.); 
the data from the ITC experiments were processed with Excel add-in cEST [20] (Section 
3.5.2.). 
 
We obtained very similar stability constants via both ITC and LT experiments and for 
either the racemic or the pure enantiomers of the lanthanide complex. The constants are 
also similar to that found for the formation of [Ln(Lac)3], which would be an analogue 
for [Tb(bpcd)(Lac)], as in both complexes Ln(III) is coordinated by three carboxylate 
moieties. The enthalpy and the entropy for the adduct formation are both positive. 
Unfavorable enthalpies are typical in charge-neutralization reactions in water; entropy 
may be favorable due to i) the substitution of the water molecules coordinated to the 
Ln(III) by Lac and ii) the increment of the disorder in the water molecules present in the 
second coordination sphere, which will be less attracted by the neutral ligand.  
 
 
  
 
Table 5.2. Stability constants and thermodynamic parameters for the formation of the adduct [bpcd-Tb-
Lac] and  stepwise formation constants for the reaction [Ln-(Lac)2] +Lac ⇌ [Ln-(Lac)3] at T = 298.15 
K and µ = 0.1 M NaCl.. 
Technique log K ΔG (kJ/mol) ΔH (kJ/mol) ΔS (J/mol·K) 
[Tb(bpcd)(Lac)]     
ITC (racemic isomer) 1.30 ± 0.09 -7.0 ± 0.1 14.44 ± 0.05 72.4 ± 0.1 
LT (S,S isomer) 1.35 ± 0.01 -7.7 - - 
LT (racemic and R,R isomer) 1.45 ± 0.01 -8.3 - - 
[Ln(Lac)3]     
Potentiometry (Ln=Tb) 1.1[21]*/ 1.15[22] - - - 
Potentiometry (Ln=Eu) 1.06[21]* / 1.26[22] - - - 
Spectroscopy (Ln=Eu) 1.38[23] - - - 
* (0.1 M NaClO4) 
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                                                    Lac 
 
 
 
 
 
 
Figure 5.2. Luminescent titration of the [Tb(R,R-bpcd)(H2O)x]+  
complex (0.03 mM) under addition of Lac (λexc=270 nm).  
 
 
 
 
 
 
Figure 5.3. a) Raw ITC output signal for the formation of the [Tb(bpcd)(Lac)] adduct; b) observed (circles) 
and calculated (solid line) cumulative heat (Qcum, stepwise sum of the Qcorr) along with the calculated 
speciation.  
 
 
+ 
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5.2.3. Structure 
The lower energy structures for the [Y(S,S-bpcd)(Lac)] adduct have been determined by 
DFT calculations (Figure 5.4.) in either, gas phase or using a polarizable continuum 
model (PCM), which simulates the solvent as a polarizable continuum medium.[24] 
Structures e and f are, respectively, structures a and b optimized with four additional 
solvating water molecules. More details in DFT calculations and the choice of the Y(III) 
anion for their performance can be found in Sections 3.4.1. and 4.2.3.. 
 
The trans-O,O and trans-Npy,Npy isomers of the [Y(bpcd)]+ complex, determined 
previously (Section 4.2.3.), where considered for the calculations. As we have already 
mentioned, [Ln(Lac)3] can be considered an analogue complex for [Tb(bpcd)(Lac)], as in 
both complexes Ln(III) is coordinated by three carboxylate moieties. Thus, as suggested 
in literature for the coordination of three Lac with Ln(III) in the [Ln(Lac)3] complex,[23,25] 
the hydroxyl group of Lac was considered to be protonated, and we contemplated the 
coordination of Lac through either the carboxylate group or the hydroxo/carboxylate 
oxygens in DFT calculations. 
 
In Table 5.3. the calculated energy differences for the a-f isomers in either, gas phase or 
PCM, are presented. As it can be observed, the lower values by using PCM (either with 
or without using additional solvating water molecules) are found for both, the trans-O,O 
isomer and the trans-Npy,Npy isomer with Lac coordinating through both, the hydroxo 
and the carboxylate oxygens, which is in agreement with the results found previously in 
literature for the [Ln(Lac)3] complex.[23,25] 
 
 
 
 
 
Table 5.3. Relative energies (kcal/mol) of the [Y(bpcd)(Lac)] isomers studied by DFT calculations 
(Figure 3.5.) in gas phase and PCM, where Ea is the reference energy for Ea-d  and Ee for Ee-f. 
Structure a b c d e f 
ΔEgas 0.0 4.3 6.3 9.7 0.0 13.6 
ΔEPCM 0.0 4.7 -0.2 1.5 0.0 9.1 
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Figure 5.4. DFT minimum energy structures for the [Y(S,S-bpcd)(Lac)] adduct. 
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As we have already mentioned, water molecules near the metal center quench the 
luminescent signal and cause shorter lifetimes. Thus, the increase in the luminescence 
and lifetimes can be explained by the substitution of the water molecules present in the 
first coordination sphere by the incoming Lac anion.[26,27] The fact that these values are 
lower for the achiral complex than for the chiral ones might have been explained by a 
higher number of water molecules in the first coordination sphere in the former one, but 
that hypothesis was immediately discarded, as the hydration number for all chiral and 
achiral Tb(III) complexes discussed in this section are very similar (2.5 < q < 2.7). Thus, 
another explanation should be found. 
 
5.2.4.2. CPL 
CPL is a chiroptical technique which is attracting a great interest due to its wide range of 
applications in technological and biomedical fields.[26,28–30] Very interestingly, this 
phenomenon may be displayed by Ln(III) in chiral environments, with high dissymmetry 
factors (glum, refer to Section 3.3.2.). It is very important, as high glum values are required 
for real applications, such as bioanalysis[31], the developing of cutting-edge technology 
LEDs[32] or the selective sensing of chiral analytes (such as lactate) by inducing a CPL 
response via the binding of this chiral analyte to the Ln(III) complex.[29,30,33–36] 
 
High glum values are reported in literature for Ln(III) complexes presenting the DACH 
backbone (Figure 4.1.).[30] Some of them are very similar to the bpcd2- complexes we 
propose, for instance cddadp2- (Figure 5.6.).[37] But, in the design of bpcd2-, the carboxylic 
moieties linked to the pyridine antenna where eliminated in order to leave additional space 
for the binding of the target biomarker. 
 
 
 
 
 
 
 
 
Figure 5.6. Ligands H4cddadp (left) and H4bpeda (right) proposed in literature[37]. 
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During CPL experiments in CD3OD we confirmed high glum for our Eu and Tb complexes 
(Tables 5.4. and 5.5.). The results for the Tb isomers turned out to be specially promising, 
as their glum values are even higher than those reported in literature for other chiral Tb(III) 
complexes (|0.044| < glum < |0.082|)[31,38,39] and similar to those found for cyclen-based 
(|0.22|)[40] and DACH-based (|0.20|)[30] Tb complexes. We would like to emphasize that, 
as also observed in our results, Eu complexes usually display higher glum values than Tb 
complexes. Considering these promising results, CPL spectra in water were recorded for 
the main band of the Tb(bpcd)Cl complex for the two enantiomers. The values obtained 
(Table 5.5. in parenthesis) were still high, which makes this Tb complex potentially 
suitable as a CPL sensing probe in aqueous solution. 
 
Table 5.4. glum values for the R,R, and S,S enantiomers of Eu(bpcd)Cl in 
CD3OD, calculated on minima or maxima of the CPL curves. 
Wavelength (nm) (R,R) (S,S) 
598 -0.9 +0.18 
607 +2.3 -0.28 
625 -0.14 -0.14 
 
 
Table 5.5. glum values for the R,R, and S,S enantiomers of Tb(bpcd)Cl in 
CD3OD, calculated on minima or maxima of the CPL curves. 
Wavelength (nm) (R,R) (S,S) 
546 +0.11 (+0.07) -0.11 (-0.06) 
586 +0.16 -0.15 
594 -0.70 +0.70 
616 +0.31 -0.31 
625 -0.11 -0.09 
 
 
5.2.4.3. CPL sensing of L-lactate 
Regarding the good results obtained in the CPL experiments with the Tb(bpcd)Cl 
complex in water, we studied the CPL response of the complex in the presence of lactate. 
CPL titrations for both enantiomers were performed separately at 546 nm upon the 
addition of Lac, from 0 to 100 equivalents (Figure 5.7.), and we observed that the 
enantiomers presented diverse trends. The (R,R) enantiomer presented a 50% variation 
from 0 to 100 equivalents of Lac, while the (S,S) enantiomer presented a lower variation 
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of 17%. The stability constants of the adducts between Lac and both enantiomers are, as 
we have already discussed (Table 5.2.), very similar. Actually, we observed that the 
racemic complex show CPL activity in the presence of Lac, as the CPL signals from the 
enantiomers do not cancel out (Figure 5.8.a). Also the response of the achiral complex 
[Tb(bped)]+ in the presence of Lac was studied (Figure 4.8.b), but no CPL signal was 
observed.  
 
 
 
 
  
 
  
 
 
 
Figure 5.7. CPL titration at 546 nm, normalized to the first titration point, for the 
a) (R,R) and the b) (S,S) enantiomer of the [Tb(bpcd)]+ complex upon addition of Lac. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8. CPL titration at 546 nm, normalized to the first titration point, for  
a) the racemic [Tb(bpcd)]+ and b) the racemic [Tb(bped)]+ complex upon addition of Lac. 
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Regarding the good results obtained for our chiral Tb complex, we decided to study its 
CPL response in a more complex matrix including Lac, in order to assess the viability of 
this potential probe for practical applications. The commercial solution Ringer’s 
lactate[41] was chosen due to its current application in hospitals for the treatment of 
metabolic acidosis and for the replacement of electrolytes and fluids after blood loses. 
This solution contains, apart from L-lactate (28.3 mM), CaCl2·2H2O (0.27 g/L), KCl 
(0.40 g/L) and NaCl (6.0 g/L). The CPL spectra were recorded in the commercial solution 
containing the racemic [Tb(bpcd) ]+ complex 5 mM), with the ratio Tb:Lac being 1:5.4. 
As expected, we observed CPL activity (Figure 5.9.), and it was in agreement with the 
previous CPL experiments performed with our complex in the presence of Lac (Figure 
5.8.a) regarding both, shape and intensity. We would like to point out the fact that Lac is 
the only chiral species in the commercial solution and, consequently, the only one capable 
of inducing the CPL activity observed. 
 
 
 
 
 
 
 
 
 
 
Figure 5.9. CPL spectrum at 546 nm for the racemic  
[Tb(bpcd)]+ (5 mM) in a commercial Ringer’s lactate solution. 
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5.2.5. Conclusions  
 
 
 
 
 
 
 
 
 
 
 
 
 STABILITY AND STRUCTURE OF THE LACTATE ADDUCT 
 
■  
 
The adduct between L-lactate and the Tb(III) complex is stable at 
temperature T = 298.15 K and ionic strength µ = 0.1 M NaCl.  
 
■ Similar stability constants are found either via ITC or LT for the (R,R) and 
(S,S) isomers and for the racemic forms of the complex. The obtained stability 
constants are also similar to those presented by Eu(Lac)3  and Tb(Lac)3. 
 
 
■ The trans-O,O isomer and the trans-Npy,Npy isomer coexist in equilibrium, 
with Lac coordinating through both, the hydroxo and the carboxylate oxygens, 
which is in agreement with the results found previously in literature for the 
[Ln(Lac)3] complex.[23,25] 
 
 
SENSING OF LACTATE 
 
■ The racemic form of [Tb(bpcd)]+ exhibits CPL activity in the presence of L-
lactate due to the diverse trends displayed by the (R,R) and (S,S) isomers. 
 
■ The luminescent response of the Tb(III) complex rises in the presence of L-
lactate until reaching a plateau at 100 equivalents of lactate. 
 
■ L-lactate was detected by the racemic [Tb(bpcd)]+ in a commercial solution in 
the presence of  other electrolytes. 
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5.3. Sensing of bicarbonate 
5.3.1. Introduction 
Carbonate presents the protonation constants pKa1 = 9.87 and pKa2 = 6.11 at 298.15 K, 
and pKa1 = 9.67 and a pKa2 = 6.04 at 323 K, all under µ = 0.1 M (Equations 5.3.a and 
b).[42] 
 𝑝𝐾𝑎1 = [𝐻𝐶𝑂3−][𝐶𝑂32−][𝐻+]                                        (Equation 5.3.a) 
 𝑝𝐾𝑎2 = [𝐻2𝐶𝑂3][𝐻𝐶𝑂3−][𝐻+]                                        (Equation 5.3.a) 
 
 
If we use the Henderson-Hasselbalch equation (Equation 5.1.), we can easily calculate 
the approximated ratios of carbonate/bicarbonate and bicarbonate/carbonic acid expected 
under physiological pH (Equations 5.4.a and b) and critically low pH (Equations 5.4.c 
and d) at 298.15 K (calculations at 323 K omitted, as the constants for both temperatures 
are comparable). 
 
 
7.4 = 6.11 + log ( [bicarbonate] / [carbonic acid] )  20:1                    (Equation 5.4.a) 
7.4 =  9.87 + log ( [carbonate] / [bicarbonate] )  1:295                         (Equation 5.4.b) 
6.8 = 6.11 + log ( [bicarbonate] / [carbonic acid] )  5:1                    (Equation 5.4.c) 
6.8 =  9.87 + log ( [carbonate] / [bicarbonate] )  1:1174                      (Equation 5.4.d) 
 
 
 
Even considering this equation as an approximation, we may affirm that carbonate will 
be usually in the form of bicarbonate in physiological conditions. Thus, in 
carbonate/bicarbonate/carbonic acid studies for biomedical applications, the bicarbonate 
form will be considered (figure 5.10.). 
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Figure 5.10. Bicarbonate (hydrogen carbonate) anion. 
 
Abnormal bicarbonate concentrations may be related to irregular pH homeostasis and, 
consequently, to many diseases. For instance, metabolic acidosis (abnormally high 
hydrogen ion concentration) may indicate the presence of solid tumors[43] or cause chronic 
kidney disease – it has been observed that patients with chronic kidney diseases caused 
by metabolic acidosis show low serum bicarbonate concentration.[44]  
 
Other many physiological processes, apart from pH homeostasis and kidney function, 
depend on this equilibrium, such as sperm maturation and blood flow.[16,45,46] Moreover, 
bicarbonate is 10 times more concentrated than other anions present in human body’s 
fluids and tissues (except within cells, where lactate could compete with bicarbonate in 
specific cell types) (Table 5.6.).[16] Thus, the development of sensors for bicarbonate 
quantification at physiological conditions is of main importance for the study, detection 
and treatment of many diseases related to this anion and its physiological processes. 
 
 
 
 
Table 5.6. Typical concentrations (mM) of selected anions in humans.[16] 
Anion Extracellular fluid Intracellular fluid* Cerebrospinal fluid 
Bicarbonate 24-27 10-12 20-23 
Lactate 0.6-2.3 3-22 0.5-2.2 
Citrate 0.1-0.3 2-4 0.05-0.25 
Phosphate 1.2-1.3 0.8-1.2 0.15 
Chloride 104-115 3-15 115-130 
Sulfate 0.4-0.6 0.3-04 0.06-0.2 
* Concentrations may vary considerably depending on the cell type. 
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As previously discussed for lactate, fluorimetric sensors are especially convenient as they 
facilitate the development of non-invasive and miniaturized sensors, which may permit 
the commercialization of biocompatible devices with the capability of constantly 
checking the concentration of relevant biomarkers. In literature we may find many 
examples of Eu(III) and Tb(III) complexes which successfully quantify bicarbonate in 
‘physiological’ conditions.[16] Bretonniere et al.[47,48] report Eu(III) complexes, all 
containing acridone as chromophore moieties (Figure 5.11.), which present a good 
luminescent response for bicarbonate concentrations between 5 and 25 mM.  
 
Moreover, they can selectively bind bicarbonate (logK = 0.8-2.3, depending on the ligand) 
in the presence of chloride, phosphate, lactate, citrate and protein. Murray et al.[49] report 
a non-toxic (to several cell types, with an IC50 > 200 µM) Eu(III) complex (Figure 5.12., 
R = phenyl) selective for bicarbonate (logK = 3.50) and citrate (logK = 6.02), which may 
allow the monitoring of local changes of this anions within the mitochondrial region. This 
same complex and two analogues (Figure 5.12., R = phenyl, ester, carboxylate 
respectively) have also been reported by Smith et al.[50,51]; they monitored in vivo for the 
first time the concentration of bicarbonate in the mitochondria of cells. Imperio et al.[52] 
present an Eu(III) luminescent complex which selectively binds bicarbonate in the 
presence of competing anions, such as lactate and citrate. However, the stability of the 
adduct does not accomplish the conditions required in the applications. In 2013, Butler et 
al.[53] reported Eu(III) complexes capable of selectively binding bicarbonate in a complex 
medium when found in a concentration >10 mM (logK between 3 and 4, 295 K, 50% 
MeOH / 0.1 M NaCl).  
 
 
Figure 5.11. Three representative Eu(III) complexes presenting acridone chromophore moieties.[47,48] 
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Figure 5.14. Ln(III) (Ln = Eu, Tb) complex, R = phenyl, ester, carboxylate.[49–51] 
 
As already described in Chapter 4, the complexes we present in this work differ in charge, 
steric hindrance and lipophilicity. It is expected that these differences will confer them 
different affinity towards diverse analytes (selectivity towards diverse target biomarkers), 
and lipophilicity strongly affect the mobility of the complexes in the organism, which is 
a very important fact to take into account for medical sensors. Moreover, the complexes 
proposed present a 6-fold coordination (ignoring water molecules) in comparison to that 
commonly found in literature (7-fold coordination, ignoring water molecules, strongly 
pre-oriented)[16,35,47–50,52–54] which may allow them the reversible binding of more than 
one target analyte at the same time (higher affinity) when the target molecule is small 
enough, such as in the case of bicarbonate. We continued our sensing studies with the 
small, relevant biomarker bicarbonate with the library of Eu and Tb complexes introduced 
in Chapter 3, in order to not just studying their viability as bicarbonate sensors, but also 
to begin a broader study about the selectivity of these complexes towards diverse analytes 
and interferings. 
 
5.3.2. Stability 
The binding constants of the adduct between bicarbonate and some Ln(III) complexes 
with bpcd, bQcd, QC3A and PyC3A (Table 5.7.) where obtained via LT upon the addition 
of bicarbonate (Figure 5.13. as an example) to a solution containing the Ln(III) complex 
(40 µM) at T = 298.15 K, pH = 7.4 and µ = 0.1 M NaCl. The data was treated with the 
cEST program for MS Excel (Section 3.4.3.) and/or by using the Benesi-Hildebrand 
equation (B-H, Section 3.3.1.). 
 
Chapter 5  
 
82 
 
 
Table 5.7. Apparent binding constants found via luminescent titration upon the addition of 
bicarbonate for the adducts between bicarbonate and the lanthanide complexes (40 µM) at T = 
298.15 K, pH = 7.4 and µ = 0.1 M NaCl. # is the number of bicarbonates coordinated to the metal 
center. 
Complex # log K (B-H) log K (cEST) 
[Eu(bpcd)]+ 2 5.76 ± 0.08 5.83 ± 0.07 
[Tb(bpcd)] + 2 5.94 ± 0.08 - 
[Eu(bQcd)] + 2 4.62 ± 0.08 - 
Eu(PyC3A) 1 2.06 ± 0.08 2.09 ± 0.04 
Eu(QC3A) 1 3.11 ± 0.08 - 
 
 
 
 
 
 
 
 
 
Figure 5.13. Total luminescence titration of [Eu(PyC3A)] upon addition of bicarbonate. 
 
The results obtained using both data treatment methods are comparable. We also observe 
that the cationic Ln(III) complexes show higher affinity towards bicarbonate, which 
makes sense taking into account the positive charge of the former and the negative charge 
of the latter. Interestingly, their affinity constants (4.62 - 5.94) are higher than those found 
in literature for other luminescent Eu and Tb complexes with bicarbonate (usually in the 
2.6 - 3.85 range, to the best of our knowledge).  
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In addition, and as we have already mentioned, the unusual ‘open concept’ of the Ln(III) 
complexes presented in this work, with 6-fold coordination (ignoring water molecules in 
the first coordination sphere), may permit the entrance of more than one target molecule 
into the first coordination sphere, which would be much difficult for complexes similar 
to those presented in literature, usually presenting strongly pre-oriented environments 
with higher coordination numbers.[16,35,47–53] And we actually do observe that up to two 
bicarbonate anions can enter the first coordination sphere of the cationic Ln(III) 
complexes. We do not observe that behavior for the neutral complexes, which is 
reasonable, as the negative charge generated by the first coordinating bicarbonate would 
hamper the binding of an additional anion due to coulombic repulsion. 
 
 
5.3.3. Structure 
The possible structures of the 2:1 bicarbonate:complex adduct where studied by DFT 
calculations for the [Y(trans-O,O-bpcd)(H2O)2]+ complex, as the bpcd-based adducts are 
the ones presenting the highest affinity constants with bicarbonate (Figure 5.14.). The 
most stable coordination mode of the bicarbonate is the bis-monodentate one, which 
presents 10.3 kcal/mol less than the bis-bidentate isomer. 
 
 
Figure 5.14. DFT minimum energy structures in PCM water for the [Y(trans-O,O-bpcd)(H2O)2]+ adduct  
with bicarbonate considering either a)bis-monodentate or b) bis-bidentate bicarbonate coordination 
modes. 
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5.3.5. Conclusions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 STABILITY AND STRUCTURE OF THE BICARBONATE ADDUCTS 
 
■  
 
The adducts between bicarbonate and the studied Ln(III) complexes are stable 
at temperature T = 298.15 K, pH = 7.4 and ionic strength µ = 0.1 M NaCl.  
 
■ The highest affinity constants have been found for the bicarbonate adducts 
with the cationic Ln(III) complexes, in part due to coulombic attraction. 
 ■ The cationic Ln(III) complexes can bind up to two bicarbonate molecules. 
 
■ The coordination mode of the bicarbonates in the 1:2 adducts is bis-
monodentate (DFT). 
 
 SENSING OF BICARBONATE 
 
■ The increase in the bicarbonate concentration leads to a clear change in the 
luminescent intensity of the Ln(III) complexes. 
 
■ The asymmetry ratio (R) of all the complexes increases upon the addition of 
bicarbonate until reaching a plateau (10 - 20 mM bicarbonate). 
 
■ The Ln(III) complexes with bpcd present the most sensitive response towards 
bicarbonate concentration, especially in the range 0 - 10 mM, a decisive 
bicarbonate concentration range for the diagnosis of metabolic acidosis. 
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5.4. First steps towards the sensing of citrate 
5.4.1. Introduction 
Citrate has the pKa values 3.13, 4.76 and 6.40 at T = 298.15 K.[16] Thus, we expect to find 
it as a trianion at a physiological pH around 7.4 (Figure 5.16.). 
 
 
 
 
Figure 5.16. Citrate trianion. 
 
 
This anion is one of the key intermediates in the Krebs cycle of anaerobic cells and plays 
an important role in glycolysis.[16,55] Therefore, it is not difficult to deduce that it may be 
a good biomarker for certain anomalies in the organism. In fact, it is well known that low 
levels of citrate in urine (usually around 10 - 12 µmol/g) may diagnose diverse kidney 
dysfunctions and even prostate cancer (1 - 3 µmol/g).[55] This fact alone would already be 
a good pretext for the development and study of potential citrate probes but, furthermore, 
the assessment of the affinity for citrate of probes initially developed for the sensing of 
other biomarkers is also interesting in order to study the possible competence between 
potentially-interfering molecules currently found in the fluids of interest.  
 
In literature we find several examples studying citrate as either just a mere potential 
interfering[35,47,48,52,56–60] or by actually quantifying its affinity towards the studied 
probe[16,49–51,53,61,62]. In Table 5.8. we present some affinity constants found in literature 
for luminescent lanthanide complexes towards citrate. Also the charges of the binary 
complexes are reported, as the coulombic interactions between complex and citrate 
strongly affect the stability of these ternary complexes. It can be appreciated that the 
affinity constants are higher for the positively-charged Ln(III) complexes, which makes 
sense, since the interaction of the positively-charged Ln(III) complexes with citrate (with 
three negative charges) would be favoured by coulombic attraction. 
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Table 5.8. Apparent affinity constants of some luminescent Ln(III) complexes towards citrate, T = 298.15 
K, µ = 0.1 M NaCl, pH = 7.4. The highest value found in each reference is reported. Also the total charge 
of the adducts is reported * T = 295 K, ** 0.1 M NaCl, 4 mM KCl, 0.1 M HEPES and 0.9 mM NaH2PO4, 
*** 10 mM ZnCl2 
REF. 
Murray[49] 
2008 
Pal[62] 
2009 
Smith[51] 
2011 
Smith[50] 
2012 
Butler[53] 
2013 
Mc Mahon[61] 
2014 
log K 6.02 5.26** 5.21 4.80* 3.65 3.95*** 
Q binary 
complex  
+3 +3 +3 +3 -1 +1 
 
 
Recently, we have begun our studies with citrate by using the Ln(III) complexes already 
discussed in this thesis. The first step has been assessing the luminescent response and 
affinity of some of these complexes upon increasing concentration of citrate.  
 
5.4.2. First results 
Emission luminescence batch analyses were performed with [Tb(bpcd)]+, Tb(PyC3A) 
(λexc = 265 nm ) and Eu(QC3A) (λexc = 318 nm ) complexes (0.1 mM) at diverse citrate 
concentration (typically around 20 points from 0.001 mM to 7 mM). All experiments 
have been performed at pH 7.4 in 3-(N-morpholino)propanesulfonic acid (MOPS) buffer 
and 0.9% NaCl. The data treatment has been performed with the cEST program for MS 
excel (Section 3.4.3.). The constants found for the three adducts with citrate are presented 
in Table 5.9..  
 
Table 5.9. Apparent affinity constants found for some Ln(III) complexes with citrate at room temperature, 
pH = 7.4, in MOPS buffer, 0.9% NaCl.   
Complex [Tb(bpcd)]+ [Tb(PyC3A)] [Eu(QC3A)] 
log K 5.31 ± 0.30 3.76 ± 0.13 4.31 ± 0.08 
 
The highest affinity constant with citrate was obtained, as expected (coulombic 
attraction), by the cationic complex but, surprisingly, the value is comparable with the 
constants found in literature for more positively-charged Ln(III) complexes. That may be 
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due to the lower steric hindrance present in the complex we propose in comparison with 
those in literature, with more rigid, pre-organized coordination sites. 
 
5.4.3. First conclusions 
Regarding the luminescent response of the complexes upon diverse citrate concentrations 
and the relatively high affinity constants obtained for the citrate adducts, we may say that 
they are, especially the cationic [Tb(bpcd)]+, promising probes for the sensing of this 
biomarker. 
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5.5. Comparison of the results obtained 
 
Even if the luminescent response and stability of the studied Ln(III) complexes seems 
adequate for their use as either, lactate, bicarbonate or citrate probes, at physiological pH 
and ionic strength, it is also important to consider that these molecules are not found 
isolated in real matrices. Hence, we should also take into account i) which molecules are 
usually present in the concerned matrix, ii) their concentration in that medium and iii) 
their affinity towards the studied probe.  
 
 
Table 5.10. Apparent affinity constants found for the Ln(III) complexes proposed in this work with the 
studied biomarkers, at T = 298.15 K, pH = 7.4 and µ = 0.1 M NaCl. *When more than a constant value 
was reported for the same adduct (different data processing or technique, diverse isomers), the mean 
value is reported. §2:1 adducts (biomarker : Ln(III) complex) 
Complex Lac Bic Cit 
Eu(bpcd)+ - 5.80*§ - 
Tb(bpcd) + 1.35* 5.94 § 5.31 
Eu(bQcd) + - 4.62 § - 
Eu(PyC3A) - 2.08* - 
Tb(PyC3A) - - 3.76 
Eu(QC3A) - 3.11 4.31 
 
As a first approximation, we will discuss the viability of our Ln(III) complexes as 
potential probes for either of the biomarkers already discussed in view of the results and 
conclusions obtained so far. In order to ease the discussion, all the apparent stability 
constants obtained for L-lactate (Lac), bicarbonate (Bic) and citrate (Cit) with the Ln(III) 
complexes of study have been collected in Table 5.10.. The [Tb(bpcd)]+ complex has 
presented the best results in terms of both luminescent response and affinity towards the 
target biomarker. Thus, we will focus on it for this comparative analysis.   
 
In order to estimate the possible speciation of the [Tb(bpcd)]+ complex in the presence of 
Lac, Bic and Cit in real matrices, some speciation simulations have been performed using 
the Hyss program. We have studied the potential speciation in intra and extracellular 
fluids by using the adequate concentrations for all the biomarkers (Table 5.6.) and a model 
of study considering the expected species and their stability constants (Table 5.11.).  
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Table 5.11. Model used for the speciation simulation. The logβ are the overall formation 
constants of the species at T = 298.15 K and µ = 0.1 NaCl. *Values determined in this 
work. Charges omitted for clarity. [63]µ = 0.7 NaClO4. 
logβ bpcd Lac Bic Cit H Tb 
9.72* 1 0 0 0 1 0 
15.59* 1 0 0 0 2 0 
18.53* 1 0 0 0 3 0 
20.75* 1 0 0 0 4 0 
3.86[16] 0 1 0 0 1 0 
2.95[22] 0 1 0 0 0 1 
5.21[22] 0 2 0 0 0 1 
6.36[22] 0 3 0 0 0 1 
6.4[16] 0 0 0 1 1 0 
11.16[16] 0 0 0 1 2 0 
14.29[16] 0 0 0 1 3 0 
7.15[64] 0 0 0 1 0 1 
12.18[64] 0 0 0 2 0 1 
5.73[63] 0 0 1 0 0 1 
10.26[63] 0 0 2 0 0 1 
9.87[42] 0 0 1 0 1 0 
15.98[42] 0 0 1 0 2 0 
11.36* 1 0 0 0 0 1 
2.04* 1 0 0 0 -1 (OH) 1 
12.71* 1 1 0 0 0 1 
17.3* 1 0 2 0 0 1 
16.67* 1 0 0 1 0 1 
13.78 0 0 0 0 -1 (OH) 0 
 
 
In literature we find several studies regarding in vivo sensing experiments with Ln(III) 
complexes, and the concentrations of complex in this works typically range from 0.02 
mM to 10 mM,[47,49–51,53,65–67] Thus, all the simulations have been studied at diverse 
concentrations of complex in the range 0.02 - 10 mM. As it can be seen in Table 5.6., the 
concentration of Lac may vary considerably depending on the cell of study or the 
extracellular fluid, therefore calculations have been done considering diverse Lac 
concentrations. For Bic and Cit, the mean concentration in intracellular or extracellular 
fluids has been considered.  
 
In Figures 5.17. and 5.18., ten estimations of the speciation in intra and extracellular fluids 
(respectively), taking into account the cited considerations, are presented. The highly-
emitting species (the ones containing the complex, i.e. both the antenna and the emitting 
lanthanide) are represented with solid lines, and the colours represent the diverse species 
of Bic (blue), Lac (green) and Cit (orange). The pairs of Figures 5.17.a-b (intracellular, 
0.02 mM complex), 5.17.c-d (intracellular, 2.5 mM complex), 5.18.a-b (extracellular, 
0.02 mM complex) and 5.18.c-d (extracellular, 2.5 mM complex) are, respectively, very 
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similar between them (independently from the Lac concentration used), especially around 
pH 7.4. On the other hand, we observe important differences between Figures 5.17.e-f 
(intracellular, 10 mM complex) and, in addition, more than one emitting species is present 
at notable concentration at pH 7.4.  
 
In Figures 5.17. a-b and 5.18.a-b, both predominant species at pH 7.4 are Cit species, but 
just one of them, the Cit adduct with the Tb complex, is a strongly-emitting species. In 
figures 5.17.c-d, this Cit adduct is clearly predominant at that pH. Thus, we may say that, 
so far, the [Tb(bpcd)]+ complex would seem a promising probe for Cit under the studied 
conditions, but it would be necessary to avoid high complex concentrations in order to 
evade the lack of selectivity observed in Figures 5.17.e-f and the predominance of the 
binary complex observed in Figures 5.18.c-d. 
 
The luminescent response of the complex in the presence of Cit has been studied for a 
concentration of complex of 0.04 mM and concentrations of Cit in the range 0.001-3 
mM (Figure 5.19.). The response is sensitive towards Cit concentration up to 0.5 mM. 
Regarding that the typical concentrations of Cit in intracellular fluids go from 2 to 4 
mM, it would be useful to sense concentrations up to, at least, 2-3 mM, in order to 
unambiguously diagnose potential metabolic problems directly linked to low Cit 
concentrations (Section 5.4.1.).  
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Figure 5.18. Estimated speciation of the Tb(III) species in extracellular fluid considering the 
[Tb(bpcd)]+ complex, Lac (concentrations reported in the figure),  Bic (25.5 mM) and Cit (0.2 mM) 
species. The solid lines correspond to highly-luminescent emitting species (containing both, the 
pyridine antenna and the emitting Tb(III)). Charges and species below 4% formation omitted for 
clarity. 
 
 
 
 
 
 
 
 
 
Figure 5.19. Luminescent response (area under the 5D4→7Fj peak, j=5) of the [Tb(bpcd)]+ complex 
(0.04 mM) in the presence of diverse concentrations of Cit. Dots represent the experimental points, 
the solid line represents the fitting obtained by the cEST program. 
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Chapter 6 
General conclusions and future 
outlook 
 
 
The luminescent Ln(III) (Ln= Eu, Tb) complexes proposed in this work are stable at 
physiological ionic strength and pH, and are the predominant species in solution at pH 
7.4. The pyridine-based ligands efficiently sensitize both, Eu(III) and Tb(III), and the 
former lanthanide is also sensitized by the quinoline-functionalized ones. Moreover, their 
total quantum yields are in the range of values found in literature for cell imaging, with 
higher values found for the Tb(III) complexes. In addition, all of them present quenching 
water molecules in the first coordination sphere, which we expected to be substituted by 
the target biomarkers, with the resulting rise in the luminescent response. And we actually 
observed this behavior in the presence of L-lactate (Lac), bicarbonate (Bic) and citrate 
(Cit).  
 
The Lac adduct with [Tb(bpcd)]+ is stable under physiological conditions and, as 
expected, the luminescent response of the complex increased upon addition of Lactate. 
The racemic complex exhibits CPL activity in the presence of Lac, which permitted the 
sensing of this biomarker in a commercial medical solution containing Lac among other 
non-chiral electrolytes. 
 
The Bic adducts with the Ln(III) complexes of study are stable under physiological 
conditions. The cationic complexes [Eu(bpcd)]+, [Tb(bpcd)]+ and [Eu(bQcd)]+ are the 
most stable ones, and can bind up to two bicarbonate molecules. As in the case of Lac, 
the luminescence response of the Ln(III) complexes proposed clearly changes upon the 
addition of Bic, and the asymmetry ratio increases. The most sensitive response is 
achieved by the [Tb(bpcd)]+ complex, especially in the range 0-10 mM of Bic, whith is 
particularly interesting for the diagnosis of metabolic acidosis. 
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Some preliminary studies have been performed regarding the sensing of Cit. The Ln(III) 
complexes studied form stable adducts with this biomarker, being the [Tb(bpcd)]+ 
complex the most stable. The luminescent response of this complex also increased upon 
addition of Cit. 
 
Speciation simulations have been performed by using the constants obtained during this 
work and in literature, the usual concentrations of the biomarkers under study in cells and 
the typical concentrations of complex used in in vivo luminescent experiments. We 
observed that the [Tb(bpcd)]+ complex may selectively sense Cit in the presence of Lac 
and Bic, which makes this complex a very promising probe for the sensing of this 
biomarker. 
 
In regard of the results obtained, it would be interesting to perform further luminescent 
titrations of the Tb complex in the presence of Cit, but using higher concentration of 
complex, which might increase the sensibility of the response. In addition, supplementary 
experiments should be performed in order to complete an extensive study on the affinity 
and luminescent response of all the complexes proposed with Lac, Bic, Cit and further 
biomarkers and interfering molecules, for instance phosphate and ATP. Also additional 
CPL studies may be performed for the adducts with the chiral molecules under study, 
such as citrate.After that, the next step would be to test the most promising probes in vivo, 
in order to test cell viability and permeability towards the selected sensors, which would 
lead our luminescent probes one step closer to their actual application in diagnosis. 
 
 
 
 
 
 
 
 
 
 


 
